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ABSTRACT 
Obesity is a global epidemic, affecting all ages. It is one of the leading causes of preventable 
death, as it increases the risk of type 2 diabetes (T2D), hypertension, cardiovascular disease, non-
alcoholic fatty liver disease, and some cancers. Obesity is a complex disease that is caused by a 
combination of genetic and environmental factors such as diets high in fat and sedentary life 
style. Despite our increased knowledge of obesity development and progression, current obesity 
treatments have not stopped the rise in obesity rates. There are still many unknowns related to 
the underlying mechanisms of obesity that need to be investigated and understood, so that 
treatment of obesity can be more effective. To deal with the numerous variables involved with 
such studies, animal models are recommended. My dissertation centers around characterizing the 
TALLYHO/Jng (TH) mouse, a polygenic model for T2D and obesity, and identifying obesity 
gene(s) in this model. The first study focused on investigating the effect of diets high in fat and 
sucrose for the development of obesity and T2D in TH mice. Compared to normal C57BL/6J 
(B6) mice, TH mice responded more sensitively to the obesogenic diets in the development of 
obesity and type 2 diabetes, demonstrating that diets are important modulators of genetic 
susceptibility to the diseases in this model. The second study was conducted in an effort to 
identify obesity gene(s) in TH mice. We generated congenic mouse strains carrying obesity 
quantitative trait loci on chromosome 1 derived from TH mice on B6 background. Using these 
mouse strains, we determined that the distal segment of chromosome 1 from TH mice is 
necessary to cause diet induced obesity. In the last study, we demonstrated that increased pro-
inflammatory cytokine interleukin-6 levels and decreased mitochondrial respiration may be in 
part a mechanism underlying the gene-diet interaction in advancing obesity and type 2 diabetes 
in TH mice.   
1 
CHAPTER 1 
INTRODUCTION 
Abstract 
Obesity is a worldwide epidemic, affecting 650 million adults. It is defined as excess 
adiposity, where one’s body mass index is greater than or equal to 30 kg/m2. Obesity is 
considered one of the leading causes of preventable death, as it is associated with an increased 
risk of comorbidities such as type 2 diabetes (T2D), hypertension, hyperlipidemia, 
cardiovascular disease, non-alcoholic fatty liver disease, and various cancers. Obesity is a 
complex disease caused by interactions between obesity promoting environmental factors, such 
as a high fat diet, and genetic factors. Excessive adiposity can lead to adipose tissue dysfunction, 
chronic, low-grade inflammation, and mitochondrial dysfunction, all of which contribute to the 
eventual development of insulin resistance and T2D. Obesity is polygenic and many of the genes 
involved and their underlying mechanisms, including gene-diet interactions, remain unknown. 
To identify genes and regions of interest, there are several different mapping techniques that can 
be used, such as genome-wide association studies or quantitative trait loci mapping. Once 
candidate genes are found, the mechanisms in which they act can be elucidated through cell and 
animal model work to identify potential therapeutic targets. 
The Scope of the Problem 
Obesity is an international health crisis. Worldwide, obesity rates have tripled since 1975, 
with 650 million adults and 1.9 billion people considered overweight in 2016. At the same time, 
340 million children and adolescents were also reported to be obese or overweight (WHO, 2018). 
To classify individuals as overweight or obese in a population, body mass index (BMI), weight 
in kilograms divided by the square of height in meters, is commonly used. A BMI ≥ 25 signifies 
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“overweight” and a BMI ≥ 30 signifies “obese” (Nuttall, 2015). Obesity is considered one of the 
leading causes of preventable death, as it is associated with an increased risk of type 2 diabetes 
(T2D), hypertension, hyperlipidemia, cardiovascular disease, non-alcoholic fatty liver disease, 
and various cancers (Gallagher & LeRoith, 2015; Rhee, 2018). Obesity is a huge economic 
burden as the cost of obesity is estimated to be around $100 billion annually in the US 
(Panuganti & Lenehan, 2018). 
Obesity is attributed to interactions between obesity promoting environmental factors, 
such as a high fat (HF) diet, and genetic factors (Yazdi, Clee, & Meyre, 2015). However, all the 
genes involved, their underlying mechanisms, and gene/environment interactions remain largely 
unknown (Albuquerque, Nobrega, Manco, & Padez, 2017; Xia & Grant, 2013). Obesity is 
characterized by adipose dysfunction, chronic, low-grade inflammation, and mitochondrial 
dysfunction. Ultimately, insulin resistance can develop, leading to the development of T2D 
(Trim, Turner, & Thompson, 2018).  
Treating the obesity epidemic has proven difficult. The first line treatments are dietary 
and lifestyle modifications, but these long-term changes can be difficult to maintain (Brandt, 
Clemensen, Nielsen, & Søndergaard, 2018; Montesi et al., 2016). Other treatments include 
behavioral therapy, surgery, and medications (Panuganti & Lenehan, 2018). To find more 
effective therapeutic targets to treat an ever-increasing obese population, more research needs to 
be conducted.  
Adipose Tissue 
The two main forms of adipose tissue are brown adipose tissue and white adipose tissue. 
3 
Brown Adipose Tissue (BAT) 
 Brown fat, also termed “good fat,” is involved in non-shivering thermogenesis to 
maintain core body temperature (Fenzl & Kiefer, 2014; Jastroch, Oelkrug, & Keipert, 2018). 
This process begins when lipids are broken down into free fatty acids (FFA), also known as 
lipolysis. The FFA are transported to the mitochondria through the carnitine shuttle, where they 
undergo β-oxidation to generate the electron carriers NADH and FADH2, as well as acetyl 
coenzyme A (Houten & Wanders, 2010). Acetyl coenzyme A generates more electron carriers by 
entering the tricarboxylic acid (TCA) cycle (Fenzl & Kiefer, 2014). The electron carriers donate 
electrons to the electron transport chain (ETC) in the inner membrane of the mitochondria for 
oxidative phosphorylation. The electrons travel through the cytochrome complexes, pumping out 
protons and creating a proton gradient, until reaching the final electron acceptor oxygen (Fenzl & 
Kiefer, 2014). Normally, energy would be produced in the form of adenosine triphosphate (ATP) 
by ATP synthase due to the proton gradient; however, in brown adipocytes mitochondrial 
uncoupling protein 1 (UCP-1) disrupts the proton gradient by transferring protons back into the 
inner membrane of the mitochondria. Oxidative phosphorylation is uncoupled from ATP 
production, so the energy produced is released as heat, also known as thermogenesis, rather than 
ATP (Fenzl & Kiefer, 2014; Kajimura & Saito, 2014; Klingenberg & Huang, 1999).  
Brown adipocytes get their color from the large number of mitochondria within the cell. 
Brown adipocytes also have multiple small lipid droplets in the cytoplasm (Hull, 1966; Park, 
Kim, & Bae, 2014). The biology of brown adipose has been extensively studied in the recent 
years and the browning of white adipose is proposed to be a potential therapeutic target in 
obesity as brown fat can increase energy expenditure and is inversely correlated with BMI 
(Townsend & Wright, 2018). Adult human BAT deposits exist, but the ability to harness the 
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function of BAT as a possible target for obesity remains elusive. More research needs to be 
conducted in order to pharmacologically induce browning in white adipose tissue (Devlin, 2015; 
Kajimura & Saito, 2014).  
White Adipose Tissue (WAT) 
WAT is an important endocrine organ that both stores energy for the body and regulates 
whole body metabolism. When energy intake is greater than energy expenditure, adipocytes store 
the excess energy as triglycerides. These triglycerides, along with cholesteryl esters, form one 
large lipid droplet within the adipocyte. When energy expenditure is greater than energy intake, 
energy can be supplied through lipolysis (Choe, Huh, Hwang, Kim, & Kim, 2016). Adipocytes 
from WAT also contain mitochondria; however, the numbers of mitochondria are much fewer 
than those in BAT and they lack UCP-1 expression (Fujimoto & Parton, 2011; Jastroch et al., 
2018).  
More recently, it has been discovered that WAT adipocytes have the potential to express 
UCP-1 under certain circumstances, for example from exposure to cold (Young, Arch, & 
Ashwell, 1984). These UCP-1 expressing WAT adipocytes are termed brite, “brown in white,” 
or beige adipocytes and are being studied as a potential obesity treatment (Kajimura & Saito, 
2014). Beige adipocytes have a white fat-like phenotype until stimulated to a brown fat-like 
phenotype and they reside in subcutaneous tissue (Bargut, Souza-Mello, Aguila, & Mandarim-
de-Lacerda, 2017; Dehghani, Kargarfard, Rabiee, Nasr-Esfahani, & Ghaedi, 2018). They also 
have a molecular signature that differs from both mature white and brown adipocytes (Stanford, 
Middelbeek, & Goodyear, 2015). Aside from cold, stimulants of beige adipocytes include 
nutritional stimulants such as anthocyanins, flavonoids found in many fruits and vegetables, or 
curcumin, a chemical in turmeric, and certain medications such as Liraglutide, a glucagon-like 
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peptide 1 (GLP-1) receptor agonist used to treat T2D (Han et al., 2018; S. Wang et al., 2015; E. 
Zhu et al., 2016). Exercise has also been shown to stimulate browning. In the 1990s, it was 
discovered that rats that swam for 10 weeks had increased browning of WAT and increased 
mitochondrial enzyme activity (Stallknecht, Vinten, Ploug, & Galbo, 1991). This increase in 
thermogenic and oxidative capacities was repeatedly seen in multiple rodent exercise studies 
(Brenmoehl et al., 2017; Dehghani et al., 2018; Gollisch et al., 2009; Townsend & Wright, 
2018). Regulation of the browning of WAT involves multiple transcription factors, signaling 
pathways, and hormones, including fibroblast growth factor 21 (FGF21), peroxisome 
proliferator-activated receptor-γ coactivator-1α (PGC-1α), and bone morphogenetic proteins 
(BMPs), (Fisher et al., 2012; Schulz et al., 2013; Schulz et al., 2011). While research is 
promising, there have been issues translating work found in rodents to humans. For example, 
although browning have been seen in mice on a calorie-restricted diet (Fabbiano et al., 2016), 
this has not been found in humans. Rather, it has been found that effects on body fat from 
calorie-restricted diets are independent of browning/brown fat. (Barquissau et al., 2018). More 
research needs to be done to harness the energy expenditure of brown fat or brown-like fat. 
In addition to adipocytes, adipose tissue is comprised of preadipocytes, adipocyte 
mesenchymal stem cells, red blood cells, endothelial cells, smooth muscle cells, pericytes, and 
immune cells, which make up the stromal vascular fraction (SVF) (Tanaka, Itoh, Ogawa, & 
Suganami, 2018). Adipose tissue deposition and distribution can vary based on gender and 
health. Visceral adipose is adipose located around the organs and subcutaneous adipose is 
adipose tissue beneath the skin. Increased visceral adipose tissue is linked to obesity, as visceral 
tissue can release cytokines and free fatty acids directly into portal circulation (Ibrahim, 2010; 
Ritchie & Connell, 2007).  
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Adipose tissue regulates whole body metabolism by secreting adipokines and chemokines 
like leptin, adiponectin, pro-inflammatory monocyte chemoattractant protein (MCP)-1, 
interleukin-6 (IL-6), tumor necrosis factor (TNF)-α, and anti-inflammatory IL-10, and by 
responding to hormonal signals, such as glucocorticoid, which promotes adipose tissue 
expansion, and the central nervous system (CNS) (G. H. Goossens, 2008; Kershaw & Flier, 
2004). The CNS includes the parasympathetic nervous system (PNS), which promotes fat 
storage, and the sympathetic nervous system (SNS) which promotes lipolysis, increasing the 
release of FFA (Balistreri, Caruso, & Candore, 2010). 
Adipocyte Development 
Multipotent mesenchymal stem cells (MSCs) can differentiate into osteoblasts, 
chondrocytes, and adipocytes (Pittenger et al., 1999). Lineage commitment of MSCs into 
preadipocytes is dependent on extracellular factors such as the expression of bone morphogenetic 
proteins (BMPs), fibroblast growth factors (FGFs), and the silencing of Wnt and hedgehog 
signaling. Wnt and hedgehog signaling promote osteoblast differentiation (Chen et al., 2016; L. 
Hu et al., 2018). Based on lineage studies, brown adipocytes and skeletal muscle are derived 
from myogenic factor 5 (Myf5)-expressing precursor cells (Shan et al., 2013). Cell fate between 
brown adipocytes and muscle depends on transcriptional regulator PR domain containing 16 
(PRDM16). PRDM16 binds to peroxisome proliferator-activated receptor gamma (PPARγ), 
activating brown adipogenesis (Seale et al., 2008). Studies have shown that white adipocytes 
may come from predominately Myf5 negative cells, but there is evidence of Myf5 positive 
precursor cells as well, indicating that white adipocytes can come from either (Peirce, Carobbio, 
& Vidal-Puig, 2014; Sanchez-Gurmaches & Guertin, 2014).  
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Once preadipocytes differentiate into adipocytes, a process known as adipogenesis, the 
cells become sensitive to insulin and begin to uptake glucose through glucose transporter 4 
(GLUT4) (Kahn & Flier, 2000). The master regulators of adipogenesis are transcription factor 
PPARγ, which is activated by peroxisome proliferator-activated receptor gamma coactivator 1-
alpha (PGC-1α), and transcription factor CCAAT-enhancer-binding protein alpha (C/EBPα) (L. 
Hu et al., 2018). These transcription factors induce the transcriptional cascade necessary for 
adipogenesis (Siersbaek, Nielsen, & Mandrup, 2010). Adipose tissue can adapt to over-nutrition 
by expanding through hypertrophy, increased adipocyte size, and/or hyperplasia, increased 
adipocyte number through adipogenesis (Siriwardhana et al., 2013). Healthy individuals have 
white adipose tissue made up of smaller, insulin sensitive adipocytes that secrete anti-
inflammatory mediators such as adiponectin and IL-10 (Makki, Froguel, & Wolowczuk, 2013). 
Causes of Obesity 
Genetics 
Obesity is a complex disease that is believed, in part, to be caused by many genetic 
factors. Genetics research involves twin studies, adoption studies, and more recently, candidate 
gene and genome-wide association studies (GWAS). Candidate gene studies and GWAS attempt 
to identify potential genes/gene variants that are linked to obesity. Once candidate genes are 
identified, researchers try to elucidate the mechanisms that underlie obesity (Choquet & Meyre, 
2011). Monozygotic twin studies have shown fat mass concordance around 70% and dizygotic 
twins have shown fat mass concordance around 30% (Stunkard, Foch, & Hrubec, 1986; Turula, 
Kaprio, Rissanen, & Koskenvuo, 1990). In adoption studies, there is a strong correlation between 
the BMI of biological parents and those who were adopted instead of with the BMI of adoptive 
parents (Moll, Burns, & Lauer, 1991; Stunkard, Sorensen, et al., 1986). Candidate gene studies 
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for obesity were instrumental in the mid-90s for identifying genes responsible for monogenic 
obesity disorders, especially with the identification of the hormone leptin and its receptor, which 
were mutated in ob/ob and db/db mice respectively (Friedman, Leibel, Siegel, Walsh, & Bahary, 
1991; G. H. Lee et al., 1996; Zhang et al., 1994). At least 20 forms of human monogenic obesity 
disorders have now been identified, and the studies have greatly contributed to the understanding 
of energy balance in obesity (O’Rahilly, 2009). The majority of obesity cases, however, are 
polygenic. GWAS scan genetic markers of thousands of individuals for gene variants that may 
play a role in obesity. The first obesity gene identified through GWAS was “fat mass and 
obesity-associated protein” (FTO) on human chromosome 16 (Frayling et al., 2007). FTO is a 
single-stranded DNA demethylase and a co-activator of C/EBPs. C/EBPs are involved with fat 
tissue expansion (Wu, Saunders, Szkudlarek-Mikho, Serna Ide, & Chin, 2010). FTO variants 
have also been shown to affect food intake (Melhorn et al., 2018). Studies have shown that the 
FTO risk allele rs9939609, also known as A allele, is associated with increased food intake from 
selection of more energy-dense foods, increased hunger, and decreased satiety after meals (Zhou, 
Hambly, & McLachlan, 2017). 
Currently, 300 loci have been identified in polygenic obesity (Heymsfield & Wadden, 
2017). Research is being conducted to identify obesity genes within the loci and investigate their 
role in obesity development.  
There is also evidence that epigenetics increases obesity risk. In multiple studies using 
animal models, both in-utero undernutrition and maternal overnutrition increased the obesity risk 
in offspring (Jimenez-Chillaron et al., 2009; Khan et al., 2005; Vickers, 2014; Zhu et al., 2008). 
In addition, obesogenic endocrine disruptors (EDCs), or chemicals that increase adiposity (EDCs 
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further explained in the environment section) have been shown to have effects that are 
transgenerational (Chamorro-Garcia & Blumberg, 2014; Chamorro-García et al., 2013). 
Environment 
Diet- 
While there are many factors that contribute to the development of obesity, diet is one of 
the most studied. To maintain body weight, there must be a balance between energy intake and 
energy expenditure. Even a small increase in energy intake can add up over time. For example, if 
energy intake is greater than 1% of energy expenditure over a year, or about 20 calories a day, a 
person can gain 2.6 kg or 5.7 lbs. during the year (Leng, 2014). Continuous over consumption 
will lead to continuous increased energy intake, increased adiposity, and the development of 
obesity. 
Changes in food availability and manufacturing in industrialized countries have changed 
the past diet of low-calorie, high-fiber foods to a current diet of highly processed, energy-dense 
foods. Constant food cues from advertisements and the very addicting nature of certain foods, for 
example sugar which causes a dopamine stimulation similar to narcotics, have been cited as a 
challenge for maintaining or losing body weight (Berthoud, 2011; DiNicolantonio, O’Keefe, & 
Wilson, 2018). Furthermore, the sedentary, but stressful life style of the modern world may 
decrease energy expenditure and increase the chances of stress eating or mindless eating, both of 
which lead to overeating (Dallman, Pecoraro, & la Fleur, 2005; Horstmann et al., 2015).  
There is currently a major debate about the role of increased dietary lipids versus 
increased carbohydrates in the obesity epidemic. If energy balance is in check, weight should not 
be gained, but the macro-composition of food could affect other areas of metabolism or insulin 
signaling. High-glycemic-index carbohydrates have been shown to be calorie dense, low in fiber, 
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and low in satiation, and may contribute to weight gain by promoting fat storage through 
continuous insulin release (Brand-Miller, Holt, Pawlak, & McMillan, 2002; Ludwig & Ebbeling, 
2018; Radulian, Rusu, Dragomir, & Posea, 2009). Fructose, a common carbohydrate in the 
western diet, has been shown to induce leptin resistance, prevent fatty acid oxidation, and reduce 
energy expenditure (Shapiro et al., 2008). Fructose has been linked to obesity, T2D, and fatty 
liver disease (Hu & Malik, 2010; Lanaspa et al., 2012). While high-glycemic foods are 
associated with weight gain, low-glycemic index carbohydrates are seen as satiating and 
beneficial, as they contain more fiber and delay gastric emptying as well as decrease postprandial 
glycemia and insulin release (Schwingshackl, Hobl, & Hoffmann, 2015; Schwingshackl & 
Hoffmann, 2013). Multiple studies have found that a diet high in fat will increase adiposity as 
well as alter metabolic profiles by increasing blood glucose levels, lipid concentration, and 
insulin levels. Thus, diets high in fat have been associated with obesity (Boi et al., 2016; Glastras 
et al., 2016). Dietary fat; however, has been found to be important in satiety, so moderate fat 
intake is encouraged for weight loss (L. Wang, Bordi, Fleming, Hill, & Kris-Etherton, 2015). 
Diet studies that compared high carbohydrate and high fat diets showed differential effects on 
metabolism and insulin resistance, signifying the importance of the macronutrients and their 
different roles in metabolism alteration (Ble-Castillo et al., 2012; Chun et al., 2010).  
A healthy diet is recommended to treat obesity, but there is conflicting information about 
what the ideal macronutrient composition of a healthy diet would be. Dietary guidelines are 
released by the United States Department of Agriculture and United States Department of Health 
and Human Services every five years, supporting low fat diet as the optimal diet for health. 
Based on studies that showed high variability in individuals’ metabolic response to the same 
macronutrients, the reliance on one type of healthy diet would not be an effective treatment 
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(Korem et al., 2017; Zeevi et al., 2015). There are many who consume the high fat, western diet 
for example that do not become obese. Further research needs to be conducted on the effect of 
different macronutrient compositions in diets with genetics. With the incorporation of 
interpersonal variability, personalized diets may be successful in treating obesity. 
Energy expenditure- 
The development of obesity occurs when energy expenditure is less than energy intake. 
Energy expenditure includes basal metabolic rate, diet-induced thermogenesis, and overall 
physical activity (Westerterp, 2004). The shift from manual labor in industrialized countries to 
more sedentary jobs has decreased energy expenditure by more than 100 calories a day since 
1960 (Church et al., 2011). In addition, the increase in modern technology with televisions and 
phones decreased energy expenditure even further and has been correlated with the owners’ 
increased risk of obesity and type 2 diabetes (Lear et al., 2014). The combination of a more 
sedentary lifestyle with highly processed, energy dense food contributes to the development of 
obesity. For obesity treatment, a healthy diet with exercise is recommended. Studies and 
literature reviews showed physical activity improved metabolic parameters, reduced adiposity, 
reduced insulin resistance, and increased diversity of gut microbiota (Denou, Marcinko, Surette, 
Steinberg, & Schertzer, 2016; Paes, Marins, & Andreazzi, 2015; Son, Sung, Bharath, Choi, & 
Park, 2017). Physical activity includes not only vigorous workouts, but nonexercise activity 
thermogenesis (NEAT). NEAT includes everyday movements such as standing and walking. 
Increased NEAT is associated with decreased risk of metabolic syndrome, while decreased 
NEAT is associated with obesity (Malaeb, Perez-Leighton, Noble, & Billington, 2018; 
Villablanca et al., 2015).  
Pollutants/chemicals- 
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While genetics, diet, and exercise are the major contributors to obesity, they do not fully 
explain the large increase in obesity worldwide. Other environmental factors and chemicals are 
believed to play a role as well.  
Obesogens, or obesogenic endocrine disruptors, are classified as chemicals that can 
contribute to weight gain through altered metabolic processes such as increased adipogenesis and 
lipid accumulation (Darbre, 2017). An endocrine disruptor is a substance that disrupts the 
endocrine system and causes adverse effects (Legeay & Faure, 2017). Obesogens include 
environmental chemicals that people come into contact with such as pesticides and herbicides, 
detergents, plastics, and personal care products for hygiene and beauty (Darbre, 2017; 
Muscogiuri, Barrea, Laudisio, Savastano, & Colao, 2017). Exposure to the obesogens can 
happen through oral absorption, inhalation, or dermal absorption (Darbre, 2017). In addition, 
obesogens can be very detrimental to fetus development during pregnancy, increasing the risk of 
disease and developmental defects of the fetus (Braun, 2017).  
Bisphenol A (BPA) is a well-known obesogen and was used to manufacture multiple 
polycarbonate plastic products such as water bottles and food can linings. Studies have found 
evidence of measurable BPA concentrations in adults, children, adolescents and fetuses 
(Chamorro-Garcia et al., 2012; Le Corre, Besnard, & Chagnon, 2015; D. K. Li et al., 2013; R. Y. 
Wang, Abbott, Zieba, Borowsky, & Kaplan, 2017). In 2010, studies showed that 90% of people 
in the US had detectable amounts of BPA in their system despite the ban of BPA in 2008 by the 
FDA (Vandenberg et al., 2010). Low levels of BPA were shown to increase adipogenesis by 
upregulating 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1), which is associated with 
increased visceral adipose tissue, and by upregulating PPAR-γ, a master regulator in 
adipogenesis (Siersbæk et al., 2010; J. Wang, Sun, Hou, Pan, & Li, 2013). To test the effect of 
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BPA in-utero, 2D and 3D human embryonic adipose tissue models were used. BPA was found to 
upregulate adipogenic genes in-utero as well (R. Y. Wang et al., 2017).  
Air pollution has also been considered a potential obesogen. It has been associated with 
increased body weight through the increase of oxidative stress and inflammation in adipose 
tissue and through increased sedentary lifestyle. Air pollution is also associated with an increased 
risk of comorbidities such as cardiovascular disease due to pulmonary inflammation, oxidative 
stress, and elevated blood pressure (An, Zhang, Ji, & Guan, 2018; Meo & Suraya, 2015; Q. Sun 
et al., 2009; Y. Wang, Hollis-Hansen, Ren, Qiu, & Qu, 2016). Studies on fossil fuels and air 
pollution are mixed; with some showing positive correlation, some negative correlation, and 
some no correlation at all (An, Ji, Yan, & Guan, 2018).  
Gene-Diet Interaction 
Obesity is attributed to genetics, lifestyle factors such as diet, and gene-environment 
interactions. Studies have shown that a diet high in fat and/or carbohydrate may modify gene 
expression and increase the risk for obesity through changes in metabolic response and adiposity 
(Heianza & Qi, 2017; Qi, 2012). One study put Wistar Bonn Kobori (WBN/Kob) diabetic fatty 
(WBKDF) rats, which have a recessive mutation that causes leptin receptor deficiency, on a 
high-fat diet (HFD) and a fructose-rich diet (FRD). Both diets promoted obesity and 
dyslipidemia; however, only the HFD exacerbated T2D (Namekawa et al., 2017). High fat diets 
have been linked to weight gain and obesity in epidemiological, clinical, and basic science 
studies, especially diets where fat is at least 30 % of total energy of the diet, such as in the 
western diet (Bray & Popkin, 1998; Hammad & Jones, 2017; J. O. Hill, Melanson, & Wyatt, 
2000). HFD may induce obesity due to increased energy intake and increased efficiency of 
energy storage compared to carbohydrates and protein. Increased dietary fat intake and storage 
14 
cause alterations in metabolism and energy homeostasis (Hammad & Jones, 2017). On the 
contrary, some studies have shown that an increase in dietary fat may prevent/treat obesity when 
accompanied by an increase in protein (Hariri & Thibault, 2010). The type of dietary fat, 
saturated fatty acids versus unsaturated fatty acids, has been shown to modify expression levels 
of genes related to adiposity and lipid metabolism. Saturated fatty acids upregulate lipogenic 
genes for example, while unsaturated fatty acids downregulate lipogenic genes (Reynes, Palou, 
& Palou, 2017; Sampath, Miyazaki, Dobrzyn, & Ntambi, 2007). 
With a high carbohydrate diet, especially those involving high levels of fructose, lipid 
synthesis is promoted in the liver. This can lead to non-adipose lipid deposition and decreased 
insulin sensitivity (Stanhope, 2016). However, some conflicting studies have shown that the 
consumption of fructose does not cause excessive weight gain and that glucose has a similar 
effect on metabolism as fructose (van Buul, Tappy, & Brouns, 2014). Weight gain and insulin 
resistance may instead be due to an overconsumption of sugary beverages or foods (Musselman 
et al., 2011). Limiting the consumption of sugary foods/beverages seems to be an effective 
strategy for weight loss (Macdonald, 2016; Stanhope, 2016).  
Dietary treatment may be complicated in obesity as many gene variants linked to obesity 
have been found to play a role in regulating appetite and food intake, thus genetic variants may 
modify dietary intervention. Meta-analysis studies have reported success in weight loss in 
individuals that decreased fat intake, decreased carbohydrate intake, and increased protein intake 
(Qi, 2014). It should be noted, there are interindividual responses to diet. For example, a study 
showed that individuals with predominantly smaller low-density lipoprotein (LDL) particles 
responded better to a low-fat diet than those with larger LDL particles, who developed more 
atherogenic LDL (Pérusse & Bouchard, 2000). Currently, gene-diet interaction studies are 
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relatively new and face several difficulties. More replicated studies and large-scale analysis need 
to be done. But, results thus far support the important role of gene-diet interactions in obesity 
development and treatment (Heianza & Qi, 2017). 
Pathogenesis of obesity 
Energy balance occurs when energy intake is equal to energy expenditure. Humans take 
in energy in the form of carbohydrates, protein, fat, and alcohol and expel energy through resting 
metabolic rate, diet-induced thermogenesis, and physical activity (Hill, Wyatt, & Peters, 2012). 
If there is positive energy expenditure there will be weigh loss. If there is positive energy intake, 
there will be weight gain. Circulating systemic signals and signals in the gut, inform the brain 
about energy levels and fat storage to regulate energy homeostasis in order to promote weight 
stability. Obesity is the result of continuous positive energy gain and a dysfunctional energy 
homeostasis system (Schwartz et al., 2017). There are short- and long-term homeostatic 
mechanisms to regulate weight. 
The short-term homeostatic mechanism of regulation involves hunger and satiety 
hormones from the gastrointestinal tract (GI) and the CNS. Mechanoreceptor neurons in the 
stomach sense gastric distension. The distension is signaled through the vagal afferent and spinal 
sensory nerves to the hindbrain, which is involved with meal size control (Berthoud, Münzberg, 
& Morrison, 2017; Ritter, 2004). In addition, some satiation-inducing gut peptides such as 
cholecystokinin (CCK), which is secreted due to fat/protein metabolism, or glucagon-like 
peptide-1 (GLP-1), or peptides released by the pancreas such as amylin, likewise work through 
the vagal afferent nerve fibers. (Ahima & Antwi, 2008; Cummings & Overduin, 2007). If CCK, 
GLP-1, or amylin signaling is disrupted, satiety is affected and more food is consumed 
(Cummings & Overduin, 2007; Geary & Smith, 1982; Williams, Baskin, & Schwartz, 2009). On 
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the other hand, the peptide ghrelin, which is secreted from the gastric mucosa, promotes feeding. 
Ghrelin is expressed before the meal and declines during the meal (Cummings et al., 2001). If 
ghrelin is removed, mice continue to eat, indicating ghrelin may have a redundant role with 
appetite regulation (Wortley et al., 2004). 
Long-term homeostatic regulation signaling is done by leptin and insulin. Leptin is 
secreted by adipocytes and signals changes in energy balance and stored fat via receptors in 
hypothalamus region, particularly the arcuate nucleus (ARC). The ARC is a major site for 
different energy signals like ghrelin or fatty acids. Leptin is involved in a negative feedback 
loop, limiting fat mass through decreased energy intake and promoting energy expenditure. If 
leptin is decreased, there is increased food intake and fat accumulation (Morton, Cummings, 
Baskin, Barsh, & Schwartz, 2006). The ARC and leptin-sensitivity are regulated by neurons 
expressing proopiomelanocortin (POMC), which release anorexigenic peptides and are 
stimulated by leptin or insulin, as well as neurons expressing neuropeptide Y (NPY)/ agouti-
related peptide (AgRP), which are stimulated by ghrelin and inhibit POMC neurons, promoting 
feeding (Aponte, Atasoy, & Sternson, 2011; Luquet, Perez, Hnasko, & Palmiter, 2005; Morton et 
al., 2006).  
Short periods of weight gain can be reversible rather quickly, but long periods of slow 
weight gain may be adapted into an upward reset energy homeostasis. Slow progression of 
obesity is the most common development. If weight is lost due to a change in lifestyle, it is not 
uncommon to gain the weight back to the newer reset energy homeostasis (Schwartz et al., 
2017). One key player could be the hypothalamus. Obesity is associated with systemic low-grade 
inflammation as well as inflammation in adipose and the surrounding tissues due to infiltrating 
cytokines. Diet-induced obesity causes inflammatory mediator activation at the hypothalamus, 
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including in areas involved with energy homeostasis (Schenk, Saberi, & Olefsky, 2008). 
Intracellular serine kinases are activated, as they are intermediaries for inflammatory cytokines, 
which phosphorylate some elements involved with the insulin transduction pathway 
(Hotamisligil, 2003). Increased inflammation in the hypothalamus leads to insulin resistance and 
loss of effect of insulin through POMC neurons. 
Adipose Tissue Dysfunction and Obesity 
Obesity is a condition defined by excess white adipose tissue. This excess adiposity is 
due to increased energy consumption and/or decreased energy expenditure. The excess adipose 
tissue, especially excess visceral adipose tissue, is considered detrimental to health. Although 
adipose tissue expands to adapt to excess calorie consumption, there is a limit for its expansion 
capabilities. 
When the storing capacity of adipocytes is exceeded, fatty acids spillover from visceral 
adipose tissue resulting in ectopic deposits and lipotoxicity in non-adipose organs, such as the 
heart or liver. Excess lipid deposition in the heart may promote plaque buildup and excess lipid 
deposition in the liver may lead to non-alcoholic fatty liver disease (NAFLD) (G. H. Goossens, 
2008; Senoo et al., 2018; Serra, Mera, Malandrino, Mir, & Herrero, 2013).  
Obesity is characterized by adipose tissue dysfunction. Adipose tissue dysfunction occurs 
through decreased expansion through adipogenesis and increased expansion through adipocyte 
hypertrophy, leading to increased inflammation (Kloting & Bluher, 2014). In adipose tissue, 
hypertrophied adipocytes may undergo apoptosis and hypoxia develops due to limited 
angiogenesis, increasing intracellular stress (Goossens & Blaak, 2015). Apoptotic adipocytes and 
hypoxia in adipose tissue lead to increased infiltration of macrophages, and increased secretion 
of pro-inflammatory cytokines, such as TNF-α and IL-6, by both the adipose tissue and 
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infiltrating macrophages. Low-grade chronic inflammation, impaired lipid metabolism, and 
mitochondrial dysfunction occur (Balistreri et al., 2010; Kahn & Flier, 2000; Yang, Eliasson, 
Smith, Cushman, & Sherman, 2012). Over time, chronic inflammation and dysfunction can 
result in insulin resistance as well as secondary organ damage (Kloting & Bluher, 2014). 
Inflammation  
Inflammation in Healthy Adipose 
Lean adipose tissue tends to be anti-inflammatory. There are several mechanisms that 
contribute to inflammation in adipose tissue (Serbulea et al., 2018), for example, structural and 
functional changes, including extracellular matrix remodeling, that are necessary for the 
development of hypertrophic adipocytes. When expansion is healthy and gradual, there is acute 
inflammation, which is necessary for adipose remodeling. After expansion, the inflammation 
decreases as the tissue returns to metabolic homeostasis (Wernstedt Asterholm et al., 2014). In 
lean adipose tissue, “alternatively activated” class or the M2-type macrophages are the major 
population of immune cells (Wynn, 2015). M2 macrophages are immunosuppressive cells that 
help induce an anti-inflammatory state in lean adipose tissue. These macrophages remove 
dying/dead adipocytes and secrete angiogenic factors and anti-inflammatory cytokines such as 
IL-10 (A. A. Hill, Reid Bolus, & Hasty, 2014; Mantovani, Biswas, Galdiero, Sica, & Locati, 
2013; Thomas & Apovian, 2017). 
Inflammation in Obesity 
Chronic low-grade inflammation is a hallmark of obesity (Trim et al., 2018). Obesity-
associated inflammation is induced by several factors, including adipocyte hypertrophy. 
Adipocyte hypertrophy increases inflammation by activating inflammatory signaling pathways, 
increasing the release of pro-inflammatory cytokines and promoting recruitment of pro-
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inflammatory immune cells (Pirola & Ferraz, 2017). Both adipocytes and immune cells release 
pro-inflammatory cytokines (Ferrante, 2013). Constant inflammatory stimulation leads to 
systemic cytokine elevation, and eventually insulin resistance and metabolic complications 
(Alligier et al., 2012; Boden, 2008; McQuaid et al., 2011). Hypoxia also contributes to 
inflammation as increased adipocyte size can lead to poor oxygenation of adipose tissue (Serra et 
al., 2013). Hypoxia can activate toll-like receptors and the nuclear factor-κB (NF-κB) pathway to 
induce downstream expression of pro-inflammatory cytokines (Boden, 2008; J. Ye, Gao, Yin, & 
He, 2007). 
“Classically activated,” or M1 macrophages increase with increased adiposity. In 
addition, there is a correlation between increased macrophage number and whole-body insulin 
resistance in humans (Travers, Motta, Betts, Bouloumie, & Thompson, 2015). Adipose tissue 
macrophages are derived from monocytes, which differentiate in response to growth factors and 
cell-stress markers such as IL-6, interferon-γ (IFN-γ), and TNF-α (A. A. Hill et al., 2015). These 
signals polarize macrophages into the inflammatory, M1 macrophages (Castoldi, Naffah de 
Souza, Camara, & Moraes-Vieira, 2015; Trim et al., 2018). 
Fatty acids also act on the M1/M2 macrophage switch. Saturated fatty acids promote M1 
cell development, while unsaturated fatty acids promote M2 cell development. The addition of 
dietary fish oils has been shown to decrease pro-inflammatory markers and increase anti-
inflammatory markers (Pirola & Ferraz, 2017). Adiponectin, an adipokine secreted by 
adipocytes, enhances insulin sensitivity by decreasing liver gluconeogenesis and increasing fatty 
acid oxidation and glucose uptake. In addition, adiponectin is inversely correlated with 
inflammation, driving M2 polarization by increasing the expression of certain factors such as the 
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anti-inflammatory cytokine IL-10. Adiponectin has also been shown to decrease the expression 
of NF-κB, TNF-α, and reduce monocyte infiltration (Pirola & Ferraz, 2017; Tian et al., 2012). 
Continuous energy overload causes inflammation to organs peripheral to adipose tissue 
as well. Liver is a major contributor to inflammation, disrupting hepatic insulin signaling and 
reducing insulin sensitivity (Cai et al., 2005; Shoelson, Lee, & Goldfine, 2006).  
Mitochondria 
Mitochondria in Healthy Adipose Tissue 
Mitochondria are essential for cell and tissue function. In white adipose tissue, 
mitochondria are involved with metabolic homeostasis, producing ATP, branched-chain amino 
acid catabolism, fatty acid synthesis, and lipolysis (Boudina & Graham, 2014). Mitochondria are 
double membraned organelles that are directly involved in pyruvate oxidation, the tricarboxylic 
acid (TCA) cycle, fatty acid β-oxidation, and oxidative phosphorylation (OXPHOS) (Serra et al., 
2013). The electron transport chain (ETC) for OXPHOS is in the inner membrane of the 
mitochondria. During cellular respiration, electron carriers transfer electrons to the ETC to 
produce ATP for energy. The ETC is made up of complexes I-IV: Complex I is NADH 
dehydrogenase, complex II is succinate dehydrogenase, complex III is cytochrome bc1 complex 
(coenzyme Q), and complex IV is cytochrome oxidase, and then there is ATP-synthase, also 
known as complex V. The electrons move through the complexes, pumping out protons across 
the inner membrane space to create a proton gradient. Ubiquinone and cytochrome c transfer 
electrons between the different complexes (Sharma, Lu, & Bai, 2009). Oxygen is the final 
acceptor of the electrons and ATP synthase produces ATP by pumping protons down their 
concentration gradient. In addition to nuclear-encoded proteins, mitochondria have their own 
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maternally inherited circular genome that includes transcripts for the protein subunits of the ETC 
complexes (Ladoukakis & Zouros, 2017; Ryu et al., 2013).  
There is evidence of a link between mitochondria and adipogenesis. During adipocyte 
differentiation, there is increased oxygen consumption and increased mitochondrial protein 
content, indicating increased mitochondrial biogenesis. There are also changes in mitochondrial 
morphology (Goldman, Zhang, & Jin, 2011; Ryu et al., 2013; Wilson-Fritch et al., 2003). In 
addition, studies have shown that adipogenesis and mitochondrial biogenesis are coordinated as 
PPARγ, C/EBPα, cAMP response element binding (CREB) protein, and PGC-1α are major 
regulators of both processes (Ryu et al., 2013). Normal mitochondrial function has been found to 
be necessary to drive adipogenesis in adipose tissue. Mitochondrial defects have been shown to 
limit adipocyte differentiation (Boudina & Graham, 2014; Kusminski & Scherer, 2012). 
Mitochondrial Dysfunction in Obesity 
Excess adipose tissue in obesity is known to be associated with mitochondrial 
dysfunction. In obese mice, a decrease in mitochondrial mass, mitochondrial function, and 
mitochondrial DNA is observed. In both mice and humans, lower oxygen consumption rates in 
preadipocytes and adipocytes are seen in obese subjects compared to lean ones (Boudina & 
Graham, 2014). 
Mitochondrial dysfunction occurs when mitochondria are unable to manage the constant 
metabolic demands. This can lead to increased production of reactive oxygen species (ROS) and 
oxidative stress as oxygen plays a major role in the ETC. Oxidative stress from the mitochondria 
and from hypoxia in the adipose tissue further increase inflammation of inflammatory adipose 
tissue. ROS can also result in the fibrosis of adipose tissue. As adipose tissues become fibrotic, 
storage capacity and endocrine function are reduced, and ectopic lipid deposition occurs in non-
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adipose tissue. The inflammation and reduced adipogenesis lead to reduced mitochondrial 
number and mass (Bournat & Brown, 2010; de Mello, Costa, Engel, & Rezin, 2018; Kusminski 
& Scherer, 2012).  
Insulin Resistance 
Insulin, a hormone released by the beta cells of the pancreas, regulates metabolism. 
Insulin is released after the ingestion of a meal and signals for glucose uptake by the liver, 
skeletal muscle, and adipose tissue through glucose transporters, while inhibiting lipolysis. 
Excess glucose can then undergo glycogenesis or lipogenesis (Goossens, 2008; Rutkowski, 
Stern, & Scherer, 2015; Wilcox, 2005). Insulin resistance can develop from continuous over-
nutrition, where the insulin-sensitive tissues (liver, skeletal muscle, adipose) stop responding to 
insulin, linking obesity to type 2 diabetes development (Ye, 2013). Insulin resistance is in part 
attributed to chronic systemic inflammation, mitochondrial dysfunction, and adipose 
dysfunction. Beta cells in the pancreas try to adapt to insulin resistance by increasing insulin 
secretion and by increasing beta cell mass. This increase in insulin production and secretion 
eventually causes beta cell failure due to constant stress (Goossens, 2008). 
Continuous over-nutrition can trigger multiple inflammatory pathways that lead to the 
activation of IκB kinase (IKK) and related kinases. IKK phosphorylates the insulin receptor 
substrate 1 (IRS-1) at several serine residues to inhibit cellular insulin signaling (Stafeev, 
Vorotnikov, Ratner, Menshikov, & Parfyonova, 2017). The inhibitor of IκB normally binds to 
NF-κB dimers, so NF-κB remains inactive in the cytoplasm. Phosphorylation promotes 
ubiquitination and degradation of IκB, freeing NF-κB. NF-κB translocates to the nucleus due to a 
nuclear localization signal and is able to target specific genes (Baker, Hayden, & Ghosh, 2011). 
NF-κB contributes to inflammation by driving the differentiation of monocytes to M1 or M2 
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macrophages (Baker, Hayden, & Ghosh, 2011). In addition to IKK, activation of c-Jun N-
terminal kinase and mitogen-activated protein kinase can act as a negative regulator of insulin 
signaling by direct Ser/Thr phosphorylation of IRS-1 (Solinas & Karin, 2010). Dysregulation of 
insulin signaling as well as downregulation of glucose transporters and unregulated lipolysis 
results in insulin resistance (Kahn & Flier, 2000; Rutkowski et al., 2015).  
Treatment of obesity 
Prevention of obesity through education about healthy eating and exercise is the best way 
to treat obesity (Matwiejczyk, Mehta, Scott, Tonkin, & Coveney, 2018). With a rise in childhood 
obesity, treating obesity as early as possible results in the best outcome (Gortmaker & Taveras, 
2014). Obese children have more adipocytes than lean children, but losing weight will only 
reduce adipocyte size and not number. (Knittle, Timmers, Ginsberg-Fellner, Brown, & Katz, 
1979). 
Whether in childhood or adulthood, it is recommended for the patient to visit a physician 
to check for any rare or endocrinological reasons for weight gain (Wickham & DeBoer, 2015). If 
there are no abnormalities for obesity development, then treatment of obesity involves lifestyle 
interventions in diet and exercise. Therapy may be recommended as well to address emotional 
eating (van Strien, 2018). Pharmacological medications are considered a secondary treatment 
option and are available in conjunction with lifestyle change; however, these are prescribed only 
if necessary for the patient to lose weight and maintain weight loss (Patel & Stanford, 2018). The 
medications involve suppressing appetite, decreasing dietary absorption, and increasing energy 
expenditure. Contrave (Orexigen Therapeutics, United States) is one such approved obesity drug 
that reduces appetite, where clinical trials showed weight loss ≥8% over 56 weeks. (Panuganti & 
Lenehan, 2018). The most extreme and third line of treatment, bariatric surgery, may be the most 
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successful in weight loss (Patel & Stanford, 2018). Weight loss surgery is associated with 
significantly decreased BMI for a patient overtime as gastric bypass reduces hunger through 
increased anorexigenic hormones, decreased gastric distension, and enhanced gut peptide 
signaling (Shin, Zheng, Pistell, & Berthoud, 2011). To qualify for surgery, certain criteria must 
be met and there is the risk of surgical complications (Wickham & DeBoer, 2015).  
Despite our understanding of obesity, the lifestyle modifications and pharmacological 
modifications recommended are not as effective as expected, especially since the rates of obesity 
continue to rise. With dietary interventions, there is a lot of contradictory information on the best 
diet and people often have trouble with adherence to the change in lifestyle and the maintenance 
of weight loss long-term (Thom & Lean, 2017). In 2015, a study was published in Cell where 
investigators monitored glycemic responses after meals for a week for 800 people. They found 
high interpersonal variability among the group, despite everyone eating the same meals. They 
then created a machine-learning algorithm that incorporated various measured clinical 
parameters including gut microbiota profiles and self-reported lifestyle factors to predict 
glycemic responses. They tested their algorithm on 100 new people where they found the 
coefficient correlation equated to R=0.68. Next, they used the algorithm to test personal dietary 
interventions for 26 new participants. They found that those on the “good” diet had significantly 
reduced glycemic response compared to those on the “bad” diet, as well as improved glucose 
metabolism and changes in gut microbiota (Zeevi et al., 2015). The interpersonal variability may 
partly explain why diet studies can contradict one another. This study points to personally-
tailored diets as the most effective diet for obesity and T2D. As for drug treatment, mechanisms 
involved with appetite and body weight regulation are rather complex and many discontinued 
anti-obesity drugs caused severe medical complications (Kang & Park, 2012). More research 
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needs to be done on the complex mechanisms underlying obesity in order to increase drug 
effectiveness and decrease side effects. 
Type 2 Diabetes 
Diabetes mellitus type 2 (T2D) is a complex metabolic disorder. The number of people 
who have diabetes has quadrupled from 108 million in 1980 to 422 million in 2014, and there are 
likely many more who have developed T2D but are unaware of their condition (Bell, Kivimaki, 
& Hamer, 2014; WHO, 2017). The classic symptoms of T2D are increased thirst and hunger and 
increased urination. A fasting blood glucose level of 126 mg/dL or higher indicates diabetes and 
a fasting blood glucose level of 100 to 125 mg/dL indicates prediabetes (Pour & Dagogo-Jack, 
2011). Diabetes is associated with insulin resistance, hyperglycemia, dyslipidemia, oxidative 
stress, chronic inflammation, and renal dysfunction. Obesity is a risk factor for T2D and T2D can 
lead to heart disease, stroke, blindness, kidney failure, and amputations due to poor blood flow 
(Bell et al., 2014). 
Causes of Type 2 Diabetes 
Genetics 
A genetic basis for T2D has been well documented. A child with one parent with T2D 
has a diabetes risk odds ratio (OR) of 3.4-3.5. The OR becomes 6.1 if both parents have T2D 
(Nair & Baier, 2015). Twin studies have shown if one monozygotic twin has T2D then the other 
has a 90% chance of developing T2D and a dizygotic twin has a 25 to 50% chance of developing 
T2D (Pour & Dagogo-Jack, 2011). Through GWAS and meta-analysis, 69 established genetic 
loci were linked with T2D in 2014 (Hivert, Vassy, & Meigs, 2014). More recently this has 
increased to >300 novel and established loci in total (Ingelsson & McCarthy, 2018; Scott et al., 
2017), demonstrating the high polygenicity of T2D. The studies have also revealed that T2D is 
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characterized by many causal genetic variants with small additive effects on risk (Ingelsson & 
McCarthy, 2018). Many of the loci also show no known function in the pathophysiology of T2D, 
so further research is required (Nair & Baier, 2015). TCF7L2, which encodes transcription factor 
4 (TCF4), is the most studied locus for T2D. TCF7L2 is involved in the Wnt signaling pathway 
and Wnt is involved with pancreatic cell proliferation and differentiation. The risk alleles of 
TCF7L2 seem to affect beta cell function and insulin production (Florez et al., 2006; Y. Zhou et 
al., 2014). 
Medical drug treatments for T2D are very variable from patient to patient. Genetic 
variability found by GWAS may explain the variability experienced in patients on similar drug 
treatments (Pollastro, Ziviello, Costa, & Ciccodicola, 2015). Continued research will help 
increase the effectiveness of pharmacogenomics to treat T2D. Increased research may also help 
predict the risk of developing T2D from genetic information. A number of recent studies have 
tried to develop accurate genetic risk score models (X. Sun, Yu, & Hu, 2014). 
Environment 
T2D is associated with a sedentary lifestyle, as well as a poor diet. As with obesity, diet 
and exercise are key treatment options in treating T2D (Sami, Ansari, Butt, & Hamid, 2017). A 
systematic review of 60 cross-sectional and cohort studies, found decreased risk of T2D where 
there was space conducive to walking, greener neighborhoods, and quieter neighborhoods 
(Dendup, Feng, Clingan, & Astell-Burt, 2018). In addition, areas with higher air pollution, 
measured as particulate matter, had increased risk for T2D (Dendup et al., 2018). 
Epidemiological data indicate that chronic exposure to organic land pollutants (pesticides, 
herbicides) disturbs glucose metabolism and induces insulin resistance (Murea, Ma, & 
Freedman, 2012). 
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To decrease the risk of developing T2D, obesity should be treated through increased 
physical activity by exercise and NEAT and by healthy eating. High physical activity is 
associated with decreased diabetes risk, increased insulin sensitivity, and increased glycemic 
control. While there are many conflicting short-term diet studies, generally, a more plant based 
diet with reduced intake of refined grains and sugar is beneficial (Kolb & Martin, 2017). Other 
factors include quality and duration of sleep (7-8 hours), moderate tea and coffee consumption, 
and moderate alcohol consumption to decrease the risk of T2D. (Kolb & Martin, 2017). In a 
large cohort study of overweight adults with impaired glucose tolerance, there was a 58% 
reduction in diabetes through lifestyle modification and weight loss. Despite the lifestyle 
modification, 11% of the test group developed diabetes in 4 years (Knowler et al., 2002). The 
development of diabetes may be due to other environmental or genetic factors, but the best 
interventions would be before the development of diabetes or prediabetes.  
Pathophysiology of T2D 
T2D is characterized by hyperglycemia, beta cell dysfunction, and insulin resistance. 
Beta-cell dysfunction 
Decreased beta cell mass and beta cell dysfunction, where the beta cell can no longer 
increase insulin secretion to compensate peripheral insulin resistance, are important to T2D 
development (Brereton, Rohm, & Ashcroft, 2016). Beta cell dysfunction occurs as a result of 
inflammation and insulin resistance from obesity. Chronic hyperglycemia leads to increased 
oxidative stress, damaging mitochondria, and increased inflammation, increasing cytokines 
released from infiltrating immune cells in the pancreas. Compensation for insulin resistance 
results in hyperinsulinemia as well as increased hyperplasia and hypertrophy of beta cells, 
increasing beta cell mass. However, overtime, oxidative stress and inflammation cause beta cell 
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destruction and increased apoptosis, decreasing insulin secretion and beta cell mass (Cerf, 2013). 
Eventually, the beta cell population declines through apoptosis and amyloid fibrils develop 
(Pandey, Chawla, & Guchhait, 2015). 
Insulin resistance 
Obesity-related insulin resistance is a precursor to T2D as described in previous sections. 
Insulin resistance can occur from dysregulation of insulin signaling in peripheral tissues and 
downregulation of glucose transporters, causing hyperglycemia from digestion and unregulated 
release of glucose into the blood. Decreased insulin secretion further exacerbates insulin 
resistance. It should be noted that studies have shown variability of insulin resistance and beta 
cell dysfunction in those who are obese  (Pour & Dagogo-Jack, 2011).  
People with a “normal” BMI can develop T2D as well. They tend to have greater visceral 
adiposity than those who have “normal BMI” and do not have T2D. Their T2D is believed to 
have developed from genetics, adipose dysfunction, insulin resistance, hyperglycemia from 
impaired insulin secretion, and low-grade inflammation in the intestinal tract (Hammarstedt, 
Graham, & Kahn, 2012; Vaag & Lund, 2007; J. Zhou et al., 2018). 
There are several possible complications that could arise from T2D including coronary 
artery disease, diabetic nephropathy, and diabetic retinopathy (Murea et al., 2012). 
Treatment of Type 2 Diabetes 
As with obesity, prevention of T2D through education, diet, and exercise is the best route. 
Once a person is diagnosed as pre-diabetic or with T2D, treatment through lifestyle modification 
is recommended. Restricted calories and increased physical activity have been shown to reduce 
BMI and increase insulin sensitivity (Hoelscher, Kirk, Ritchie, & Cunningham-Sabo, 2013). In 
adults, these lifestyle modifications decrease glycemic levels, but there is little experimental 
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study in adolescence. The few cases available found adolescents may still lack control of 
glycemic levels (Zeitler et al., 2012). Uncontrolled glycemic levels may be due to the differences 
with the progression of T2D, as children develop hyperglycemia much more quickly and have 
more trouble adhering to lifestyle change (McGavock, Dart, & Wicklow, 2015). 
The goal of diabetes treatment involves glycemic control in the long term. Along with 
exercise and diet, treatment can often include medication such as oral antidiabetic drugs (OAD) 
(Pulgaron & Delamater, 2014; Semiz, Dujic, & Causevic, 2013). OADs include sulphonylureas, 
which stimulate insulin release and increase glucose uptake in skeletal muscles, biguanides like 
metformin, which decrease hepatic gluconeogenesis and increase glucose uptake, and 
thiazolidinediones, which bind to PPARγ and increase fatty acid uptake, increasing insulin 
sensitivity (Semiz et al., 2013). Bariatric surgery, previously mentioned as an option for obesity, 
is now being studied for its effectiveness in treating T2D. Both insulin resistance and β-cell 
dysfunction improve after surgery; however, the mechanisms behind diabetes remission remains 
incomplete as improvements are seen before dramatic weight loss (Pok & Lee, 2014). Future 
research needs to examine the interindividual differences of treatment outcomes by further 
studying genetic variants related to diabetes and drug uptake. Studies also need to be done on 
elucidating mechanisms caused by bariatric surgery and how to achieve juvenile glycemic 
control.   
Animal Models for Obesity Research 
Animal models are extremely useful in obesity and T2D research for understanding the 
regulation of energy balance. The advantages of using animal models include whole genome 
sequence availability, the variety of strains, ease of genetic manipulation, ability to localize 
disease genes, and ease of variable control (Yazdi et al., 2015). There are many genetic models 
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available that can be monogenic and polygenic. The first animal models that were involved in 
obesity and T2D research include single gene mutations of leptin and the leptin receptor in ob/ob 
and db/db mice, respectively, which were developed in The Jackson Laboratories in the 1950s 
(Hummel, Dickie, & Coleman, 1966; Ingalls, Dickie, & Snell, 1950; Lee et al., 1996; Zhang et 
al., 1994). Most human obesity and T2D cases, however, are polygenic. Monogenic models are 
useful for studying severe phenotypes, but they are not an accurate representation of most human 
obesity and T2D phenotypes (Mittwede, Bergin, Clemmer, & Xiang, 2015; Nilsson, Raun, Yan, 
Larsen, & Tang-Christensen, 2012). There are several different approaches to learn more about 
energy regulation and the underlying mechanisms of obesity and T2D in polygenic models. One 
method is to study different mutations in rodents by exposing them to different mutagens. By 
exposing rodents for example to radiation, major loss-of-function mutations can be discovered 
more quickly. This method, however, involves a large number of random mutations and thus 
phenotyping all the various offspring can be costly (Speakman, Hambly, Mitchell, & Król, 
2008). Another method is genetically engineering mutations for over-expression or knock-out of 
certain genes; these mutations can be global or cell or tissue specific. This method has led to the 
formation of several transgenic and knock-out and knock-in models. A potential issue with these 
models may be the formation of compensatory mechanisms due to the targeted mutations 
(Speakman et al., 2008). The next method involves selective breeding for obesity and T2D 
phenotype to generate polygenic models. Polygenic models for obesity/T2D have many of the 
same symptoms as humans including hyperinsulinemia, hyperlipidemia, hyperglycemia, 
hypertension, and insulin resistance. Several polygenic mouse strains are used for research, 
including the New Zealand Obese mouse (NZO), C57B6 late-onset obesity mouse (LOO), and 
the TALLYHO/JngJ (TH) mouse. (Joost & Schurmann, 2014; Lutz & Woods, 2012). There are 
31 
also studies on obesity-resistant models such as the rat strains S5B/PI and Lou/C or A/J mice 
(Nilsson et al., 2012). Rodents are the most commonly used animal model for obesity and T2D 
research, but other animals such as chickens, pigs, dogs, Göttingen minipigs, and non-human 
primates have been studied as well (Nilsson et al., 2012; Speakman et al., 2008). Non-human 
primates have the closest phylogenetic relationship to humans and thus may be good model for 
research, but the model has a long-life span and gestation period and would most likely provide a 
small sample size (Vaughan & Mattison, 2016).  
When using animal models, quantitative trait loci (QTL) mapping can be conducted to 
locate regions of genome that are responsible for obesity or T2D phenotypes and then congenic 
lines and bioinformatics can be used to identify the possible candidate genes. Beyond genetics, 
environmental effects that contribute to obesity and T2D can be studied. For example, effects of 
diet can be studied using diet-induced obesity models (DIO) (Nilsson et al., 2012).  
This thesis is focused on the TALLYHO/Jng mouse model. The TH mouse is a polygenic 
model for human obesity and T2D that develops hyperleptinemia, hyperinsulinemia, insulin 
resistance, glucose intolerance, hyperlipidemia, and hyperglycemia (Denvir et al., 2016). TH 
mice originated from male Theiler’s original mice that were glycosuric and polyuric. They were 
imported to The Jackson Laboratory in 1992, where the male mice were selectively bred for 
hyperglycemia (Leiter, 2001). Previous studies report a genetic basis for obesity and T2D 
through QTL mapping in TH mice (Kim & Saxton, 2012b).   
Objectives of the study 
TH mice are a polygenic model for obesity and T2D, whose genetic basis has been well 
documented. Diet studies in TH mice have not been reported. The second chapter of this thesis is 
dedicated to studying the effect of nutritionally modified diets in the development of obesity and 
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T2D in TH mice, testing our hypothesis of the presence of interplay between genetic 
susceptibility and obesogenic diets in this model. The third chapter builds off previous QTL 
mapping studies performed on the F2 generation of mice from a TH and B6 cross. We 
hypothesized that a TH allelic difference at the obesity QTL on chromosome 1 confers 
susceptibility to obesity. To test this hypothesis, we generated congenic mouse strains carrying 
the chromosome 1 QTL derived from TH on a B6 background and characterized them. Finally, 
the fourth chapter involves a mechanism study in respect to inflammation and mitochondrial 
dysfunction in relation to obesity and T2D. We hypothesized that TH mice had increased 
inflammation and decreased mitochondrial respiration in advancing obesity and T2D.   
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Abstract 
The co-epidemic of obesity and type 2 diabetes is associated with increased morbidity 
and mortality.  Genetic factors are highly involved in the development of these diseases, in the 
form of interactions of multiple genes within obesogenic and diabetogenic environments, such as 
a high fat diet.  The TALLYHO/Jng (TH) mouse is an inbred polygenic model for human obesity 
and type 2 diabetes.  In order to further develop the TH mouse as a clinically relevant model, we 
investigated diet dependence of obesity and type 2 diabetes in TH mice vs. C57BL/6 (B6) mice.   
TH and B6 mice were weaned onto a standard rodent chow, semi-purified high-sucrose 
low-fat (HSLF), or semi-purified high-sucrose high-fat (HSHF) diet and maintained on these 
diets throughout the study.  Despite similar fat contents in HSLF diets and chow, both B6 and 
TH mice responded to HSLF diets, with increases in adiposity.  TH mice, but not B6 mice, 
exhibited significantly higher adiposity with severely aggravated glucose intolerance and 
hyperglycemia on HSHF diets compared to the other diets.  HSLF diets also advanced diabetes 
in TH mice compared to chow, but it did not surpass the effects of HSHF diets.  The severe 
glucose intolerance and hyperglycemia in TH mice on both HSLF and HSHF diets were 
accompanied by significantly reduced Glut4 mRNA levels compared to B6 mice. The present 
data demonstrate that diets are important modulators of genetic susceptibility to type 2 diabetes 
and obesity in TH mice.  The interplay between heredity and dietary environment in TH mice 
appears to amplify insulin resistance, contributing to severe glucose intolerance and diabetes. 
Introduction 
Globally, the prevalence of obesity and type 2 diabetes is increasing dramatically.  The 
estimated total numbers of adults who were overweight (BMI 25kg/m2) or had obesity (BMI 
30kg/m2) in 2005 were 937 million and 396 million, respectively, and the respective number is 
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projected to be 1.35 billion and 573 million by 2030 (Kelly, Yang, Chen, Reynolds, & He, 
2008).  In 2013, 382 million people had diabetes and this number is expected to be 595 million 
by 2035 (Guariguata et al., 2014).  Type 2 diabetes is the most common form of human diabetes, 
accounting for 90% to 95% of diagnosed diabetes patients (Gavin, Freeman, Shubrook, & 
Lavernia, 2011). 
The etiology of obesity and type 2 diabetes involves multiple factors, including multiple 
susceptibility genes and environmental factors (Bouret, Levin, & Ozanne, 2015).  The global 
epidemics of obesity and type 2 diabetes are attributed to the interaction between westernized 
environmental factors and a genetic predisposition to these diseases (Walker et al., 2015).  A 
major contributing environmental factor of obesity and type 2 diabetes is a diet high in fats 
(Hariri & Thibault, 2010).  The vulnerability to high-fat diets in developing obesity and type 2 
diabetes differs among individuals, which is most likely explained by genetic factors.     
The TALLYHO/Jng (TH) mouse is a genetic model for human obesity and type 2 
diabetes (Kim & Saxton, 2012b).  The genetic basis of obesity and type 2 diabetes in TH mice 
follows a polygenic pattern of inheritance (Kim & Saxton, 2012b), closely resembling human 
cases (Grarup, Sandholt, Hansen, & Pedersen, 2014).  Obesity in TH mice develops in both 
males and females, whereas the type 2 diabetes develops in males, preceded by glucose 
intolerance (Kim & Saxton, 2012b; Kim et al., 2001b).  To further develop the TH mouse as a 
clinically relevant model, in the present study we analyzed diet dependence of obesity and type 2 
diabetes in TH mice vs. C57BL/6 (B6) mice.  The data demonstrate the high sensitivity of TH 
mice to dietary high fat during the development of obesity and type 2 diabetes, providing strong 
evidence that diets are important modifiers of genetic susceptibility to type 2 diabetes and 
obesity.  
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Materials and Methods 
Animals and diets 
TH mice used in this study were from our breeding colony that has been maintained since 
2001 (Kim & Saxton, 2012b).  B6 mice were purchased from The Jackson Laboratory (Bar 
Harbor, ME, USA) and/or bred in our facility.  All mice were allowed free access to food and 
water in a temperature and humidity-controlled room with a 12-hour light/dark cycle.  At 3-4 
weeks of age, mice were weaned onto standard rodent chow (Purina 5001, PMI Nutrition, 
Brentwood, MO, USA), semi-purified high-sucrose low-fat (HSLF) diets (D12489B) or semi-
purified high-sucrose high-fat (HSHF) diets (12266B) (Research Diets, New Brunswick, NJ, 
USA) and maintained on these diets throughout the study.  The HSLF diets contain a comparable 
sucrose content but a lower fat content than HSHF diets and the fat calories are replaced mainly 
with cornstarch.  Chow contains a similar fat content but a lower carbohydrate content than 
HSLF diets and the carbohydrate calories are replaced with proteins.  Detailed composition of 
chow and semi-purified HSLF and HSHF diets are presented in Table 1.  All animal studies were 
carried out with the approval of Marshall University Animal Care and Use Committee.  
Body composition  
Quantitative magnetic resonance imaging was used to assess body composition, including 
fat mass and lean mass in mice using EchoMRI-100 whole body composition analyzer (Echo 
Medical Systems, Houston, TX, USA).  A median of quintuple measurements for each animal 
was used as recommended by the manufacturer.  
Intraperitoneal glucose tolerance test  
Mice were fasted overnight and injected with glucose in saline intraperitoneally (1mg/g 
body weight).  Blood was collected via submandibular bleeding at 0, 15, 30, 60 and 120 minutes 
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after the injection.  Blood glucose levels were measured and calculated using a One Touch 
Ultra2 Blood Glucose Monitoring System (Diagnostics Direct, Cape May Court House, NJ, 
USA).  In this system, the maximal level of blood glucose that can be determined is 600 mg/dl.   
Non-fasting glucose, triglyceride, total cholesterol, and insulin levels in the circulation 
Blood was drawn in the morning via submandibular bleeding and plasma was obtained 
by centrifugation (1,200g) at 4ºC.  Blood glucose levels were measured as mentioned above, and 
plasma levels of total cholesterol (Thermo Electron, Louisville, CO, USA) and free and total 
glycerol (Sigma, St. Louis, MO, USA) were determined using commercial colorimetric assays.  
Plasma true triglyceride concentrations were estimated by subtraction of free glycerol from total 
glycerol.  Plasma insulin levels were determined using an ELISA kit (Crystal Chem, Downers 
Grove, IL, USA). 
Indirect calorimetry, locomotor activity, and food intake   
Heat production, respiratory exchange ratio (RER), food intake, and locomotor activity 
were measured in mice using an eight-chamber Comprehensive Laboratory Animal Monitoring 
System (CLAMS) (Columbus Instruments, Columbus, OH, USA) as described previously (Mao, 
Dillon, McEntee, Saxton, & Kim, 2014).  Locomotor activity was determined as ambulatory 
count, the number of times different infrared beams were broken in either the x- or y-axes during 
an interval.  
Real-time quantitative RT-PCR  
Total RNA was isolated from epididymal adipose tissue using RNeasy Lipid Tissue Midi 
Kit (Qiagen, Valencia, CA, USA) according to the manufacturer's instructions.  Total RNA (2 
μg) was then reverse-transcribed with SUPERSCRIPT RT using oligo d(T)12-18 as primer to 
synthesize first-strand cDNA according to manufacturer’s instructions (Thermo Fisher Scientific, 
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Waltham, MA, USA).  The primers used for the real-time PCR were proprietary for the insulin 
receptor substrate 1 (Irs1) (Qiagen) or synthesized (Sigma) using sequences obtained from the 
published literature for insulin receptor substrate 2 (Irs2) (Arai et al., 2013) and glucose 
transporter 4 (Glut4) and 36B4 (Dalen, Ulven, Bamberg, Gustafsson, & Nebb, 2003).  The real-
time PCR reaction was carried out in 1x SYBR Green PCR core reagents as described previously 
(Stewart, Kim, Saxton, & Kim, 2010) using the StepOneTM Real-Time PCR system (Thermo 
Fisher Scientific).  For each sample, duplicate amplifications were performed and the average 
measurements used for data analysis.   
Statistical analysis 
Physiological data analysis: Variables were analyzed with analysis of variance, using a 
fixed effects factorial model of strain and diet and interaction.  To satisfy normality and equal 
variance requirements a few variables were log transformed.  Variables measured at 14+ weeks 
of age were tested for age effects, and an age covariate added to the model when 
significant.  Least squares means were compared using Fisher’s protected LSD at a 5% 
significance level. 
Real-time qRT-PCR data analysis: Duplicate threshold cycle times were averaged for 
each mouse, and differences tested using a two-way ANOVA in SAS software (Cary, NC, USA), 
with an interaction contrast (housekeeping vs. gene interaction with strain or diet) used to 
estimate ∆∆Ct.  Data are presented as relative fold-change (Livak & Schmittgen, 2001). 
Results 
In order to examine the sensitivity of TH mice to dietary high fat in the development of 
obesity and type 2 diabetes, TH and B6 mice were weaned onto a regular chow diet, semi-
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purified HSLF diet, or semi-purified HSHF diet and maintained on these diets throughout the 
study.  
 
HSLF, high-sucrose low-fat diets; HSHF, high-sucrose high-fat diets 
Table 1. Diet composition 
 
Body weight and body fat changes 
At 5-6 weeks of age, when the animals were on the diets for only about 2 weeks, HSHF 
diets increased adiposity in TH mice at a greater extent than B6 mice (Fig.1A and B).  At this 
young age, TH mice also exhibited larger body weight and body fat in HSLF diets compared to  
 Chow HSLF HSHF 
kcal/gm 3.36 3.9 4.41 
 gm% kcal% gm% kcal% gm% kcal% 
Protein 23.9 28.5 16.4 16.8 18.5 16.8 
Carbohydrate 48.7 58.0 70.8 72.6 56.7 51.4 
Fat 5.0 13.5 4.6 10.6 15.6 31.8 
Total  100  100  100 
Notable Ingredient       
Sucrose 3.7  24.6  27.8  
Starch 31.9  42.3  20.6  
Crude fiber 5.1      
Cellulose   2.5  2.8  
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Figure 1. Body weight and body fat mass in C57BL/6 (B6) and TALLYHO/Jng (TH) mice fed 
chow, high-sucrose low-fat (HSLF) and high-sucrose high-fat (HSHF) diets. A and B present 
data at 5-6 weeks age and C and D present data at 16-17 weeks of age. Data were reported as 
means ± SEM. A and B: n=4 (chow), n=7 (HSLF), n=10 (HSHF) for B6 mice and n=9 (chow), 
n=8 (HSLF), n=7 (HSHF) for TH mice. C and D: n=45 (chow), n=12 (HSLF), n=12 (HSHF) for 
B6 mice and n=29 (chow), n=14 (HSLF), n=11 (HSHF) for TH mice. Group means labeled with 
different letters are significantly different (P<0.05). 
 
the chow diet, while no diet effects were seen in B6 mice at this age (Fig. 1A and B).  At 16-17 
weeks of age, TH mice were highly responsive to HSHF diets both by increasing body weight 
and body fat (Fig. 1C and D).  Interestingly, at this age HSLF and HSHF diets were equally 
obesogenic in B6 mice compared with chow (Fig. 1C and D).   
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Figure 2. Intraperitoneal glucose tolerance test (IPGTT) in B6 and TH mice on chow, 
HSLF and HSHF diets at (A) 5-6 and (B) 16-24 weeks of age. Area under the curve of glucose 
levels during the IPGTT was also presented.  Data were reported as means  SEM.  A: n= 4 
(chow), n=6 (HSLF), n=8 (HSHF) for B6 mice and n=7 (chow), n=8 (HSLF), n=7 (HSHF) for 
TH mice.  B: n=7 (chow), n=7 (HSLF), n=5 (HSHF) for B6 mice and n=6 (chow), n=9 (HSLF), 
n=8 (HSHF) for TH mice.  Group means labeled with different letters are significantly different 
(P<0.05). 
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B6: C57BL/6, TH: TALLYHO/Jng, BW: body weight, RER: Respiratory exchange ratio.   Data 
are means  SEM.  Group means labeled with different letters are significantly different 
(P<0.05).  The values for B6 and TH mice on chow at 17-19 weeks were previously reported 
(Mao et al., 2014).  
 
Table 2. Indirect calorimetry, locomotor activity, and food intake in B6 and TH mice on 
chow, HSLF, and HSHF diets over a 24-hour period 
 
Intraperitoneal glucose tolerance test  
When we evaluated mice at the young age of 5-6 weeks, HSHF diets induced earlier 
development of glucose intolerance in TH mice (Fig. 2A).  At 19-24 weeks of age, TH mice 
exhibited a significantly impaired glucose tolerance compared with B6 mice on chow (Fig. 2B).  
While the severity of glucose intolerance was maintained on HSLF diets, it became markedly 
worse on HSHF diets in TH mice (Fig. 2B).  Fasting blood glucose levels (values at 0 minute 
during IPGTT) were also significantly elevated in TH mice on HSHF diets compared to chow 
diets (29334 vs. 11740 mg/dl) (Fig. 2B). 
  B6   TH  
 Chow  HSLF HSHF Chow  HSLF  HSHF  
6-10 week       
N 7 5 7 6 5 7 
BW (g) 23.80.50DE 24.30.60D 22.80.47E 26.80.54C 34.30.56B 29.10.47A 
Heat (kcal/hr) 0.400.02D 0.540.02B 0.440.01C 0.440.02C
D 
0.620.02A 0.580.01AB 
RER 0.870.02C 0.990.02A 0.900.02BC 0.890.02B
C 
0.950.02AB 0.870.02C 
Ambulatory 
count 
125051648B 142471958
B 
261561546A 12647176
4B 
134911833B 151301555B 
Food (g) 4.360.31A 3.980.37AB 3.210.29B 4.040.34A
B 
3.950.35AB 3.640.30AB 
17-19 week       
N 7  7 7 5  6 5 
BW (g) 27.080.89D 32.970.89C 32.430.89C 37.381.05
B 
34.390.96C 43.971.05A 
Heat (kcal/hr) 0.450.02C 0.560.02B 0.560.02B 0.550.02B 0.580.02DB 0.620.02A 
RER 0.930.01C 0.980.01A 0.890.01D 0.910.01C
D 
0.950.01AB 0.840.01C 
Ambulatory 
count 
12535946B 17284946A 16163946A 94391119
C 
108661022BC 106901119B 
Food (g) 3.790.31AB 3.890.31A 3.330.31AB 4.190.37A 4.030.34A 2.890.37B 
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Indirect calorimetry, locomotor activity, and food intake   
In order to determine if the differences in body mass and composition resulted from 
differences in energy intake and/or energy expenditure, we assessed food intake, locomotor 
activity, and respiratory parameters using CLAMS.  Overall, with increased body mass the heat 
production (kcal/hr) per animal increased at both young (6-10 week) and old (17-19 week) ages 
(Table 2).  However, when the heat production was normalized by body weight (kcal/kg/hr) 
(Tschop et al., 2011), TH mice showed decreased heat production on HSLF diets at young age 
and on chow and HSHF diets at old age (Table 2).    
RER reflects the whole-body oxidation rate of carbohydrate and fat; ~0.7 suggests 
complete reliance on fat oxidation and ~1.0 carbohydrate oxidation.  Average RER over a 24-
hour period reflected the dietary energy sources in our study, exhibiting the highest on HSLF 
diets without strain differences at both young and old ages (Table 2).  Mice usually exhibit a 
stable fasting RER that is considerably lower than fed RER during the 12-hr light phase, as they 
primarily consume food during the 12-hr dark phase (Vaitheesvaran, LeRoith, & Kurland, 2010).  
Interestingly, RER during the dark phase was significantly lower in TH mice than B6 on HSLF 
and HSHF diets at both ages (Table 2).    
There were no significant differences in food intake (gram consumed) among groups over 
a 24-hr period at both ages (Table 2).  Notably, % of total food intake during the light phase was 
overall higher on HSLF and HSHF diets than on chow, with greater extend in TH mice (Table 
2).  The concomitant decrease in percentage of food consumed during the dark phase may be 
reflected as the decreased RER during the dark phase in TH mice shown above.  
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TH mice showed decreased locomotor activity compared to B6 mice especially at older 
age, for all diets (Table 2).  The overall decrease in activity was attributed to specific reduction 
in activity during the dark phase, but not from the light phase (Table 2).  
 
 
Figure 3. Circulating (A) glucose, (B) insulin, (C) triglyceride, and (D) total cholesterol 
levels in B6 and TH mice on chow, HSLF and HSHF diets at 14-28 weeks of age (non-
fasting).  Data were reported as means  SEM.  N=7 (chow), n=7 (HSLF), n=8 (HSHF) for B6 
mice and n=8 (chow), n=10 (HSLF), n=9 (HSHF) for TH mice.  Group means labeled with 
different letters are significantly different (P<0.05). 
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Circulating glucose, insulin, triglyceride, and cholesterol levels 
Non-fasting glucose, insulin, triglyceride, and total cholesterol levels in circulation were 
measured at 14-28 weeks of age.  Unlike reported in earlier publications (Kim et al., 2001b; Kim 
et al., 2006), TH mice maintained at the Marshall University vivarium did not develop severe 
hyperglycemia when fed chow (Fig. 3A).  However, blood glucose levels were significantly 
elevated in TH mice fed HSLF or HSHF diets, with a greater value in HSHF, compared to chow 
(Fig. 3A).  Along with the advanced hyperglycemia, plasma insulin levels were also higher in 
TH mice on HSLF and HSHF diets compared to chow but did not reach statistical significance 
possibly due to the large variability (Fig. 3B).  The severe hyperglycemia was accompanied by 
an increase in plasma triglyceride in TH mice on HSLF and HSHF diets, while there were no 
changes in plasma triglyceride across the diets in B6 mice (Fig. 3C).  Whereas total plasma 
cholesterol levels were overall significantly higher in TH mice than B6 mice, both strains 
trended towards higher cholesterol values when fed HSHF diets vs. chow (Fig. 3D).  
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Figure 4. Gene expression in epididymal adipose tissue from B6 and TH mice on chow, 
HSLF and HSHF diets.  Total RNA was extracted from epididymal fat pad and cDNA 
synthesized.  The gene expression of Irs1, Irs2 and Glut4 was measured by real-time PCR.  The 
values were normalized to 36B4 gene expression in each sample.  Panels in the first and second 
columns represent diet effects in each strain; changes in gene expression were expressed as fold 
change relative to mean values for mice on chow in each strain.  Panels in the third column 
represent strain effects; changes in gene expression were expressed as fold change relative to 
mean values for B6 mice in each diet.  N=4 (chow), n=3 (HSLF) and n=3 (HSLF) for B6 mice 
and n=4 (chow), n=5 (HSLF) and n=5 (HSHF) for TH mice. *P<0.05, **P<0.01, ***P<0.001   
 
Gene expression of insulin resistance-related genes in adipose tissue 
We measured expression levels of genes related to insulin resistance including Irs1, Irs2 
and Glut4 in adipose tissue of mice at 22-28 weeks of age.  There were significant interactions of 
strain with diet.  In B6 mice, mRNA levels of the Irs1, Irs2 and Glut4 genes were significantly 
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elevated on HSLF diets compared to chow (Fig. 4, first column).  However, these increases were 
blunted in TH mice on HSLF diets (Fig. 4, second column).  On the other hand, HSHF diets did 
not significantly affect mRNA levels of these genes in either strain compared to chow, except the 
elevation of Irs1 in TH mice.  Focusing on strain differences within diets, TH mice had lower 
expression of the Irs1 gene on HSLF diets, but higher expression on HSHF diets compared to B6 
mice (Fig. 4, third column).  TH mice also had higher expression of the Irs2 gene compared to B6 
mice on chow and HSHF diets.  Despite these divergent changes in Irs1 and Irs2, TH mice 
exhibited significantly lower Glut4 gene expression compared to B6 mice on HSLF and HSHF 
diets.            
Discussion 
The present data demonstrate that diets are important modulators of genetic susceptibility 
to type 2 diabetes and obesity in TH mice.  The HSHF diets used in this study were a purified 
form of the condensed milk rodent diet (Lauterio, Bond, & Ulman, 1994) that was known to be 
effective in identifying obesity-susceptible and obesity-resistant populations (Levin, Triscari, & 
Sullivan, 1983a, 1983b).  The fat content of the HSHF diets is moderate compared with that of 
other high-fat diets (Lauterio et al., 1994) and more closely mimics the average American diet 
consisting of 35% of energy from fat (Last & Wilson, 2006).  In our study, it was clear that chow 
diets have weight-reducing and diabetes-delaying effects compared to semi-purified diets, as 
previously reported (Mirhashemi et al., 2011).  In B6 mice, despite the similar fat content with 
chow, semi-purified HSLF diets exerted a weight-increasing effect to the degree of HSHF diets 
at older ages studied.  This similar degree of adiposity increasing effects of these two diets may 
be due to the moderate fat content in HSHF diets because other purified high-fat diets with 
higher fat content were effectively obesogenic compared with purified low-fat diets in B6 mice 
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(Black et al., 1998; C. M. Hill et al., 2015; Opara, Petro, Tevrizian, Feinglos, & Surwit, 1996).  It 
is also possible that these effects are due to the short duration of HSHF diet feeding.  Indeed, 
other studies reported that the same HSHF diets effectively increased adiposity in B6 mice with 
longer duration of feeding (Heber et al., 2014), but not with short duration (Cope et al., 2007).   
HSLF diets also increased adiposity in TH mice at young age, but this effect did not 
surpass the effect of HSHF diets at older age.  These data suggest that the obesogenic effect of 
semi-purified (and sucrose) diets precedes the obesogenic effect of dietary fat in TH mice.  
Similar phenomenon was also observed in obese NZO mice in which semi-purified diets (with or 
without sucrose) effectively increased adiposity compared to chow at early stage of feeding 
(Mirhashemi et al., 2011).  In the NZO mouse, a weight gain in response to high fat diets began 
to show at later stage of the feeding; but the study was terminated before it became statistically 
significant (Mirhashemi et al., 2011).  Chassaing et al. (2015) observed a rapid obesogenic effect 
of semi-purified low-fat diets compared to chow in mice and demonstrated that this effect was 
associated with lack of soluble fiber in semi-purified diets, which causes cecal and colonic 
atrophy and microbiota-dependent promotion of adiposity.  As dietary fibers, only insoluble 
fiber, cellulose, is present in the HSLF and HSHF diets (Table 1), and therefore we speculate that 
the early obesogenic effect of HSLF diets in TH mice may be attributed to the lack of soluble 
fiber in this semi-purified diet.  In future, it is a great interest to test whether this effect is 
microbiota dependent.   
TH mice showed reduced locomotor activity levels, especially at older ages, compared 
with B6 mice without diet differences, suggesting that the reduced locomotor activity may not 
directly correlate with increased body mass in response to high-fat diets in TH mice.  Currently, 
the significance of reduced locomotor activity in the pathogenesis of obesity and diabetes in TH 
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mice is unclear.  It is known that there is wide variation among inbred mouse strains in the level 
of locomotor activity (Mhyre et al., 2005).  Among multiple inbred strains tested, the B6 strain 
was near the top of locomotor activity measures (Mhyre et al., 2005).  Therefore, it is possible 
that the cage activity differences between TH and B6 mice may reflect genetic background 
differences of these two strains.  It is also possible that the presence of physical limitations 
secondary to the increased body mass may cause the hypo-activity in TH mice.   
Although our food intake measurement was limited to the short time period while 
animals were housed in the CLAMS, daily food intake in TH mice was overall comparable with 
B6 mice.  Therefore, we hypothesize that TH mice have a higher energy storage efficiency than 
B6 mice through unknown mechanisms.  A potential mechanism may include an alteration in 
energy partitioning.  For example, fat in the body may be in line for oxidative processes in 
skeletal muscle or for storage as triglyceride in adipose tissue, such that preferential partitioning 
of energy to storage over oxidative processes may be overwhelming in the development of 
obesity.  This hypothesis, however, remains to be tested.  A weight gain usually results in 
compensatory increases in energy expenditure (Leibel, Rosenbaum, & Hirsch, 1995).  In our 
study, although the observed heat production (kcal/hr) was comparable between TH and B6 mice 
or even greater in TH mice, heat production normalized by body weight (kcal/kg/hr) was lower 
in TH mice especially at old ages, possibly reflecting insufficient compensatory increases in 
energy expenditure.  Collectively, our working hypothesis is that the positive energy balance in 
TH mice may be attributed to the combined effect of increased energy retention efficiency and 
inadequate energy expenditure.  
When the major energy source was carbohydrates, as found in HSLF diets, B6 mice 
significantly increased insulin receptor substrates Irs1 and Irs2 and glucose transporter Glut4 
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mRNA in the adipose tissue.  These transcriptional elevations were totally absent in the adipose 
tissue from TH mice on HSLF diets, which led to lower levels of Irs1 and Glut4 mRNA in TH 
mice than B6 mice.  TH mice also had lower Glut4 mRNA expression than B6 mice on HSHF 
diets.  Glucose uptake by adipose tissue is dependent on insulin-mediated glucose transport, 
mainly provided by insulin-regulated GLUT4 glucose transporter (Scheepers, Joost, & 
Schurmann, 2004).  Therefore, we infer that down-regulation of Glut4 mRNA expression is one 
of the mechanisms by which HSLF and HSHF diets induce the severe hyperglycemia in TH 
mice.  
We have maintained our inbred colony of TH mice since 2001, which was derived from 
The Jackson Laboratory (Kim & Saxton, 2012b).  In the present study, it was noticed that while 
the obesity and glucose intolerance were sustained, the hyperglycemia was largely reduced in our 
colony of TH mice on chow maintained at Marshall University, compared with that reported in 
our previous publications on TH mice (Kim et al., 2001b; Kim et al., 2006).  This reduced 
hyperglycemia may reflect either a genetic divergence that occurred in our sub-colony after 
many generations (Leiter, 2001) or an environmental factor reducing hyperglycemia.  Phenotypic 
divergence in TH mice was also previously observed among sub-colonies at different 
institutions, including the earlier onset of hyperglycemia in the Calgary-based colony (Cheng, 
Jiang, Ding, Severson, & Triggle, 2007).  Nonetheless, the present data demonstrate that the 
interplay between heredity and dietary factors in TH mice can maximize and/or synergize the 
susceptibility to hyperglycemia.    
In summary, this study provides important information about diet dependence of obesity 
and type 2 diabetes in TH mice.  TH mice are very sensitive to the dietary fat content in 
advancing obesity and diabetes.  The TH mouse will be a clinically relevant model for obesity 
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and type 2 diabetes where genetic factors interplay with dietary factors, serving as a useful tool 
in developing and testing therapeutic targets.  
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Abstract 
The TALLYHO (TH) mouse presents a metabolic syndrome of obesity, type 2 diabetes, 
and hyperlipidemia.  Highly significant quantitative trait loci (QTLs) linked to adiposity 
(proximal) and hypercholesterolemia (distal) were previously identified on chromosome (Chr) 1 
in a genome-wide scan of F2 mice from C57BL/6J (B6) x TH.  In this study we generated 
congenic mouse strains that carry the Chr 1 QTLs derived from TH on a B6 background; B6.TH-
Chr1-128Mb (128 Mb in size) and B6.TH-Chr1-92Mb (92 Mb in size, proximally overlapping).  
We characterized these congenic mice on chow and high fat (HF) diets.  On chow, B6.TH-Chr1-
128Mb congenic mice exhibited a slightly larger body fat mass compared with B6.TH-Chr1-
92Mb congenic and B6 mice, while body fat mass between B6.TH-Chr1-92Mb congenic and B6 
mice was comparable.  Plasma total cholesterol levels were significantly higher in B6.TH-Chr1-
128Mb congenics compared to B6.TH-Chr1-92Mb congenic and B6 mice.  Again, there was no 
difference in plasma total cholesterol levels between B6.TH-Chr1-92Mb congenic and B6 mice.  
All animals gained more body fat and exhibited higher plasma total cholesterol levels when fed 
HF diets than fed chow, but these increases were greater in B6.TH-Chr1-128Mb congenics than 
in B6.TH-Chr1-92Mb congenic and B6 mice.  These results confirmed the effect of the 128Mb 
TH segment from Chr 1 on body fat and plasma cholesterol values and showed that the distal 
segment of Chr 1 from TH is necessary to cause both phenotypes.  Through bioinformatic 
approaches we generated a list of potential candidate genes within the distal region of Chr 1 and 
tested Ifi202b and Apoa2.  We conclude that Chr 1 QTLs largely confer obesity and 
hypercholesterolemia in TH mice and can be promising targets for identifying susceptibility 
genes.  Congenic mouse strains will be a valuable resource for gene identification.   
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Introduction 
Obesity is associated with many comorbidities such as type 2 diabetes and coronary heart 
disease and affects 13% of the adult population worldwide, making it a major global health 
concern (Flynt & Daepp, 2015). Hyperlipidemia characterized by increased plasma lipids, 
namely cholesterol and triglyceride, also signifies an increased risk of cardiovascular disease and 
often coexists with obesity (Erion & Corkey, 2017).  An important component in the 
development of obesity (Loos & Janssens, 2017; Yazdi et al., 2015) and hyperlipidemia (Dron & 
Hegele, 2016) is genetic factors.  Although there are rare monogenic forms of obesity and 
hyperlipidemia, the genetic susceptibility to common forms is polygenic (Dron & Hegele, 2016; 
Loos & Janssens, 2017). Environmental factors are also a critical component in the development 
of obesity and hyperlipidemia, which is more likely the result of interplay between genes and 
environments with varying contributions in each individual (Doo & Kim, 2015; Marais, 2013). 
Among many environmental factors, nutrition is a strong connection between these interplays 
and especially, consuming food high in fat content is well known to promote obesity and 
hyperlipidemia (Doo & Kim, 2015; Marais, 2013). 
The TALLYHO/Jng (TH) mouse is a polygenic model for human obesity and type 2 
diabetes and characterized by increased adiposity, insulin resistance, hyperglycemia, and 
hyperlipidemia (Kim et al., 2001a).  In previous mapping study using F2 progeny of C57BL/6 
(B6) and TH mice, we have identified two major quantitative trait loci (QTLs) on chromosome 
(Chr) 1; one linked to increased fat pad weight near D1Mit215 and the other linked to 
hypercholesterolemia near D1Mit113 (Stewart et al., 2010).  Later, we named these QTLs; 
Tabw3 for the adiposity peak and Tachol1 for the hypercholesterolemia peak (Kim & Saxton, 
2012b).  To confirm the QTLs and develop a strategy for positional cloning of the responsible 
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gene(s), in the present study, we generated and characterized congenic mice carrying these QTLs 
derived from the TH strain on a B6 genetic background.   
Materials and Methods 
Animals and diets 
B6 mice were purchased from The Jackson Laboratory (Bar Harbor, ME) and maintained 
in our animal facility and TH mice used for construction of congenic strain were from our 
breeding colony.  All mice had free access to food and water in a temperature and humidity-
controlled room with a 12-h light/dark cycle.  At 4 weeks of age, mice were weaned onto 
standard rodent chow (14% kcal from fat, Purina 5001, PMI Nutrition, Brentwood, MO) or high 
fat (HF) diets (32% kcal from fat, 12266B, Research Diets; New Brunswick, NJ) and stayed on 
these diets throughout the study.  Mice were euthanized by CO2 asphyxiation, and blood was 
collected by cardiac puncture and plasma obtained by centrifugation (1,200g) at 4ºC and stored 
at −20°C.  Tissues were collected, frozen in liquid nitrogen and stored at −80°C.  All animal 
studies were carried out with the approval of Marshall University Animal Care and Use 
Committee.  
Construction of congenic mice 
Mice congenic for the Chr 1 QTL genomic region were generated by marker-assisted 
backcrossing (Kim et al., 2005).  Briefly, B6 female and TH male mice were crossed to yield F1 
and then F1 was backcrossed with B6.  The progeny were then genotyped with single sequence 
length polymorphism (SSLP) markers to select heterozygotes for the QTL. Selected 
heterozygotes were backcrossed again with B6 mice.  This procedure was repeated 10 times, at 
which point female and male heterozygotes were crossed to obtain offspring homozygous for TH 
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alleles.  Homozygous mice were then interbred to maintain congenic lines.  The congenic 
segment stretched from D1Mit213 to D1Mit113.  
Genotyping by PCR 
Genomic DNA was isolated from tail tips of mice using Gentra Puregene Mouse Tail Kit 
(Qiagen, Valencia, CA) for genotyping.  SSLP primers synthesized (Sigma, St. Louis, MO) 
based on sequences from Mouse Genome Informatics (http://informatics.jax.org/) were assayed 
after PCR of genomic DNA by 3% agarose (Amresco, Solon, OH) gel electrophoresis and 
visualized with ethidium bromide (Thermo Fisher Scientific, Marietta, OH) staining.  
Body composition  
Quantitative magnetic resonance imaging was used to assess body composition including 
fat mass and lean mass in mice using EchoMRI-100 whole body composition analyzer (Echo 
Medical Systems, Houston, TX).  A median of quintuple measurements for each animal was 
used (Parkman et al. 2016). 
Indirect calorimetry, locomotor activity, and intake of food and water   
An eight-chamber Comprehensive Laboratory Animal Monitoring System (CLAMS) 
(Columbus Instruments, Columbus, OH) was used to measure heat production, respiratory 
exchange ratio (RER), food intake, water intake, and locomotor activity (Stewart et al., 2012).  
All mice were acclimatized to monitoring cages for 24 hours prior to an additional 48 hours of 
recordings under the regular 12-hour light-dark cycle.  In this system, heat production (kcal/hr) is 
calculated by multiplying the calorific value [CV = 3.815 + (1.232 x RER)] by the observed VO2 
(Heat = CV x VO2).  Heat production was then normalized by body weight to calculate energy 
expenditure (kcal/kg/hr) (Tschop et al., 2011).  RER is the ratio between the VCO2 and VO2 
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(RER = VCO2/VO2).  Locomotor activity was determined as ambulatory count, the number of 
times different infrared beams were broken in either the x- or y-axes during an interval.     
Intraperitoneal glucose tolerance test  
Mice were fasted overnight and injected with glucose in saline intraperitoneally (1mg/g 
body weight).  Blood was collected via submandibular bleeding at 0, 15, 30, 60 and 120 minute 
after the injection.  Blood glucose levels were measured and calculated using a One Touch 
Ultra2 Blood Glucose Monitoring System (Diagnostics Direct, Cape May Court House, NJ).   
Non-fasting plasma insulin, triglyceride, and total cholesterol levels 
Plasma insulin levels were determined using an ELISA kit (Crystal Chem, Downers 
Grove, IL).  Plasma levels of total cholesterol (Thermo Electron, Louisville, CO) and free and 
total glycerol (Sigma) were determined using commercial colorimetric assays.  Plasma true 
triglyceride concentrations were estimated by subtraction of free glycerol from total glycerol.   
RNA isolation and real-time quantitative PCR (qRT-PCR) 
Total RNA was isolated from epididymal adipose tissue and liver using RNeasy Plus 
Universal Midi Kit and RNeasy Midi Kit, respectively, according to the manufacturer’s 
instructions (Qiagen).  Total RNA (2 μg) was reverse-transcribed with SUPERSCRIPT RT using 
oligo dT as primer to synthesize first-strand cDNA in 20-μl volume according to manufacturer’s 
instructions (Invitrogen, Waltham, MA).  The primers used for the qRT-PCR for the interferon 
activated gene 202B (Ifi202b) gene were synthesized (Sigma) using sequences obtained from the 
published literature (forward: 5-GGCAATGTCCAACCGTAACT-3 and reverse: 5- 
TAGGTCCAGGAGAGGCTTGA-3) (Kimura et al., 2014) and the primers for apolipoprotein 
A-II (Apoa2) gene were proprietary (PPM05347B, Qiagen).  The real-time PCR reaction was 
carried out in a 25-µl volume in 1x SYBR Green PCR core reagents (Qiagen) containing 1 µl 
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cDNA template diluate (1:5, v/v) and 6 pmol primers using the StepOneTM Real-Time PCR 
system (Thermo Fisher Scientific).  For each sample, duplicate amplifications were performed 
and the average measurements used for data analysis.  The 36B4 gene was used as a control to 
calculate the difference in average threshold cycle (∆Ct) values (Stewart et al. 2010).  
RT-PCR and sequencing of the Ifi202b gene 
The diluate cDNA described above was PCR amplified for Ifi202bNZO exon 1 and part of 
exon 2 using the Expand Long Template PCR system (Roche, Indianapolis, IN).  The specific 
primers were forward (5-CCCTCT TCCTTTACACCCAAC-3) and reverse (5- 
GCCTGGGACAGATGTCTC TT-3) derived from Mus Musculus Ifi202b gene mRNA 
sequences (GenBank: JX945582.1) (H. Vogel et al., 2013).  The PCR products were directly 
sequenced with primers originally used to amplify the PCR products.  Sequencing was carried 
out automatically with fluorescent tags (Marshall University Genomics Core Facility).  
Statistical analysis 
Physiological data analysis: Variables were analyzed with analysis of variance, using a 
fixed effects factorial model of strain and diet and interaction.  Least squares means were 
compared using Fisher’s protected LSD at a 5% significance level. 
Real-time qRT-PCR data analysis: Duplicate threshold cycle times were averaged for 
each mouse, and differences tested using a two-way ANOVA in SAS software (Cary, NC, USA), 
with an interaction contrast (housekeeping vs. gene interaction with strain or diet) used to 
estimate ∆∆Ct.  Data are presented as relative fold-change (Livak & Schmittgen, 2001). 
Bioinformatic analysis 
We used a previously published catalog of sequence variants in the TH mouse (relative to 
the B6 strain) (Denvir et al., 2016) to list all variants lying between the markers D1Mit498 
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(position 135,687,493 bp on Chr 1 in the GRCm38 genome build) and D1Mit361 (186,261,999 
bp on Chr 1).  We restricted these to variants with the potential to alter the protein sequence: 
namely those with sequence ontology terms “frameshift_variant,” “inframe_deletion,” 
“inframe_insertion,” “missense_variant,” “stop_gained,” “stop_lost,” “initiator_codon_variant,” 
“splice_region_variant,” “splice_acceptor_variant,” or “splice_donor_variant.”  We extracted 
molecular function and biological process terms for the genes containing each of these variants 
from the Gene Ontology (GO) database (Ashburner et al., 2000; The Gene Ontology, 2015).  We 
further restricted this collection of genes to contain only those that were associated to GO terms 
containing any of “cholesterol,” “fat,” “lipid,” “lipoprotein,” “lipase,” “glucose,” or “metabolic 
process,” to obtain a list of potential susceptibility genes. 
Results 
Generation of congenic mice for the obesity and hypercholesterolemia QTLs  
In previous mapping study, we have identified two major QTLs on Chr 1; one linked to 
fat pad weight (Tabw3) near D1Mit215 and the other linked to plasma cholesterol levels 
(Tachol1) near D1Mit113 (Kim & Saxton, 2012b; Stewart et al., 2010).  We established a 
congenic line by introgressing a TH-derived genomic fragment containing both Tabw3 and 
Tachol1, defined by the flanking markers D1Mit213 and D1Mit113 (minimum of 128 Mb in 
size), onto B6 background for 10 generations.  After the 10th backcross generation, the offspring 
were intercrossed to generate B6.TH-Chr1-128Mb congenic mice (Fig. 5).  Using this congenic 
line we generated a second congenic line, B6.TH-Chr1-92Mb, carrying a smaller fragment of 
Chr 1 with only Tabw3, defined by the flanking markers D1Mit213 and D1Mit498 (minimum of 
92 Mb in size) (Fig. 5).   
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Figure 5. B6.TH-Chr1 congenic intervals on chromosome 1.  Genetic markers shown at the 
top were used to allelotype the congenic interval.  The open and filled boxes represent a 
C57BL/6 (B6) and TALLYHO (TH) allele, respectively. Mb: Megabase 
 
Increased adiposity and plasma cholesterol levels in B6.TH-Chr1-128Mb, but not in 
B6.TH-Chr1-92Mb, congenic mice 
When animals were fed a standard rodent chow, B6.TH-Chr1-128Mb congenic mice 
exhibited a small increase in body fat mass compared with B6.TH-Chr1-92Mb congenic and B6 
mice, while body fat mass between B6.TH-Chr1-92Mb congenic mice and B6 mice was 
comparable (Fig. 6A).  When fed HF diets, all animals had more body fat than when fed chow, 
but the increase was greater in B6.TH-Chr1-128Mb congenic mice than either B6.TH-Chr1-
92Mb congenic or B6 mice (Fig. 6A).  Again, body fat mass between B6.TH-Chr1-92Mb 
congenic and B6 mice was comparable on HF diets (Fig. 6A).  The increased adiposity in 
B6.TH-Chr1-128Mb congenic mice on HF diets was accompanied by moderate increases in 
plasma insulin levels (Fig. 6B) and slightly impaired glucose tolerance during IPGTT (Fig. 6C), 
indicating some degree of insulin resistance.   
Plasma total cholesterol levels were significantly higher in B6.TH-Chr1-128Mb congenic 
mice compared to B6.TH-Chr1-92Mb congenic and B6 mice on chow (Fig. 6D), confirming the 
presence of the Tachol1 hypercholesterolemia QTL in the distal region of Chr 1.   
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Figure 6. (A) Body fat mass (14 wk), (B) plasma insulin levels (14-25 wk), (C) 
intraperitoneal glucose tolerance test (14-18 wk), and plasma (D) total cholesterol and (E) 
triglyceride levels (20-27 wk) in B6, B6.TH-Chr1-128Mb congenic, and B6.TH-Chr1-92Mb 
congenic mice fed chow and high fat (HF) diets (males).  Data were reported as means  SEM 
(N is indicated in each bar).  Group means labeled with different letters are significantly different 
(P<0.05). wk: weeks of age      
 
HF diets induced an increase in total plasma cholesterol in all three groups compared to 
chow, with the greatest degree in B6.TH-Chr1-128Mb congenic mice (Fig. 6D).   Plasma 
triglyceride levels were also significantly higher in B6.TH-Chr1-128Mb congenic mice 
compared to B6.TH-Chr1-92Mb congenic and B6 mice on chow (Fig. 6E).  While HF diets 
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induced an increase in plasma triglyceride levels in B6 mice, no increases were shown in both 
congenic mice.    
These results confirmed the effect of the 128Mb TH segment from Chr 1 on body fat and 
plasma cholesterol values and showed that the distal segment of Chr 1 from TH is necessary to 
cause both phenotypes.   
Energy expenditure, locomotor activity, and food and water intakes   
We measured energy expenditure and intake and locomotor activity of B6, B6.TH-Chr1-
128Mb and B6.TH-Chr1-92Mb mice on chow and HF diets by CLAMS and summarized in 
Table 3.  Overall, with increased body mass the heat production (kcal/hr) per animal increased 
with HF diet feeding compared to chow.  However, when the heat production was normalized to 
body weight (kcal/kg/hr), B6.TH-Chr1-128Mb congenic mice exhibited lower values than 
B6.TH-92Mb congenic and B6 mice on both chow and HF diets.  
RER values were generally lower when animals were placed on HF diets compared to 
chow, demonstrating that whole body substrate metabolism was shifted towards fat oxidation.  
Additionally, compared to chow, in general animals consumed less food in grams on HF diets, 
balancing the total kcal intake.  Water intake was also overall lower on HF diet.  However, there 
was no genotype effect on RER, food intake, or water intake in either diet.   
B6.TH-Chr1-128Mb congenic mice showed somewhat decreased locomotor activity 
compared to B6 and B6.TH-Chr1-92Mb mice on both diets, but it did not reach statistical  
significance. 
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  Chow   HF diets  
 B6  B6.TH-
128Mb 
B6.TH-
92Mb 
B6 B6.TH-
128Mb   
 B6.TH-92Mb   
N 17 15 9 7 4 13 
BW (g) 27.92 0.57C 30.73 0.61B 30.16 0.79B 32.43 0.89B 37.35 1.18A 30.95 0.66B 
Heat        
kcal/hr 0.45 0.01C 0.44 0.01C 0.46 0.01C 0.56 0.01A 0.55 0.01A 0.51 0.01B 
kcal/kg/hr 15.970.26BC 14.440.28D 15.370.36C 17.280.41A 14.820.54CD 16.680.30AB 
RER 0.92 0.01AB 0.91 0.01BC 0.93 0.01A 0.89 0.01CD 0.87 0.01D 0.89 0.01CD 
Food  
g 
 
3.930.15AB 
 
3.900.16BC 
 
4.450.21A 
 
3.330.24CD 
 
3.170.32D 
 
3.310.18D 
kcal 13.200.57A 13.110.60A 14.950.78A 14.680.89A 13.981.17A 14.610.65A 
Drink (ml) 3.540.17A 3.220.18AB 3.780.23A 2.720.26BC 2.400.34C 2.870.19BC 
Ambulatory 
count 
162101106AB 136231178AB 173951520A 161631724AB 116482280B 162841265AB 
 
RER: respiratory exchange rate 
ABCD means in a row with no common letter differ (P<0.05) 
Table 3. Energy expenditure (heat production), respiratory exchange rate (RER), 
locomotor activity (ambulatory count), and food and water intakes in B6, B6.TH-Chr-
128Mb congenic and B6.TH-Chr1-92Mb congenic mice on chow and HF diets over a 24-
hour period (males, 19-23 weeks of age)  
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Figure 7. Expression of Ifi202b in B6 and congenic mice. (A) PCR amplification of exon 1 
and part of exon 2 from cDNA (epididymal adipose tissue) of B6, B6.TH-Chr1-92Mb, B6.TH-
Chr1-128Mb, and TH mice using a primer set of F and R as indicated in the scheme, (B) 
sequence comparison of the PCR product of TH to the sequence of NZO derived from GenBank 
accession number JX945582, and (C) the mRNA levels of Ifi202b in epididymal adipose tissue.  
Data were reported as means  SEM (N=3-4 each group, 17-27 weeks of age).  *P<0.05.  
 
The Ifi202b gene and Apoa2 gene in B6.TH-Chr-128Mb congenic mice  
The Ifi202b gene maps to the distal region of mouse Chr 1, near the D1Mit113, Tachol1 
QTL.  It has been known that the gene expression levels of Ifi202b are closely associated with 
the obesity phenotype mediated by Nob3 obesity QTL identified from F2 population of NZO and 
B6 strains; mRNA of Ifi202b was generated by the NZO allele but not by the B6 allele (Vogel et 
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al., 2012). The B6 allele of Ifi202b contains a deletion that comprised exon 1 and the 5-flanking 
region of Ifi202b, causing the lack of mRNA (Vogel et al., 2017; Vogel et al., 2012).  
We performed PCR with primers corresponding to exon 1 and exon 2 of Ifif202b on the 
cDNA from adipose tissue in B6, congenic, and TH mice.  B6.TH-Chr1-128Mb congenic and 
parental TH mice produced a PCR product, while B6 and B6.TH-Chr1-92Mb congenic mice did 
not as expected (Fig. 7A).  We sequenced the PCR product of TH mice and found that they are 
the same as NZO except for one SNP in exon 1 (Fig. 7B).  We then measured gene expression 
levels of Ifi202b in adipose tissue of B6 and congenic mice.  Once the data were normalized to 
B6 mice having an expression value of one, B6.TH-Chr1-128Mb congenic mice had a relative 
expression value over 4 folds that of B6 mice, while B6.TH-Chr1-92Mb congenic mice had a 
comparable value to that of B6 mice on chow (Fig. 7C).  The gene expression of Ifi202b was 
significantly up-regulated in adipose tissue of B6.TH-Chr1-128Mb congenic mice when fed HF 
diets compared to chow (Fig. 7D).   
The Apoa2 gene is located near the Tachol1.  An Apoa2b allele, characterized by Ala-to-
Val substitution at amino acid residue 61, has been proposed to be hypermorphic in increasing 
plasma cholesterol levels in mice (J. Suto, Takahashi, & Sekikawa, 2004; J. I. Suto & Kojima, 
2017). The TH mouse carries the Apoa2b allele, table 4 (Stewart et al., 2010). We examined the 
Apoa2 gene expression in liver from B6 and B6.TH-Chr1-128Mb congenic mice.  While the 
Apoa2 gene expression levels were comparable between B6 and B6.TH-Chr1-128Mb congenic 
mice on chow, they were about 2-fold higher in B6.TH-Chr1-128Mb congenic than B6 mice on 
HF diets (Fig. 8).   
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Figure 8. The mRNA levels of Apoa2 in liver from B6 and B6.TH-Chr1-128Mb congenic 
mice on chow and HF diets (males, 15-24 weeks of age).  Changes in gene expression were 
expressed as fold change relative to mean values for B6 mice.  Data were reported as means  
SEM (N=5-7 each group).  *P<0.05.  
 
Bioinformatic analysis of the distal region of Chr 1  
We previously conducted a whole genome sequencing analysis for the TH mouse and 
generated a complete catalog of variants (relative to the B6 strain) (Denvir et al., 2016). We used 
this catalog to search potential candidates in the distal region of Chr 1.  There were 167,833 
SNPs and 36,284 indels in the region flanked by D1Mit498 and D1Mit361; of these, 934 SNPs 
and 89 indels had the potential to directly alter the protein product.  These variants occurred in 
252 unique genes, of which 223 had molecular function or biological process terms associated 
with them in the GO database.  This list of genes included Apoa2 and Ifi202b.  There were three 
missense variants in Apoa2 and 11 missense variants in Ifi202b (Table 4). 
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Nucleotide change (B6-TH) Amino acid change (B6-TH) Amino acid position 
Apoa2   
T-A D-E 43 
A-G M-V 49 
C-T A-V 61 
Ifi202b   
A-C S-A 432 
T-A T-S 379 
A-G L-P 350 
A-T F-I 292 
T-C K-E 204 
G-A T-I 187 
T-A I-F 142 
A-C I-M 141 
T-A I-F 127 
T-C E-G 109 
Table 4. Missense variants occurring in Apoa2 and Ifi202b. 
 
We further filtered the list of 223 genes to include only those whose associated GO terms 
included “cholesterol,” “fat,” “lipase,” “lipoprotein,” “metabolic process,” or “glucose.”  The 
filter resulted in a list of 36 genes.  These genes, the type of variant(s) that occur in them, and 
their relevant associated GO terms are shown in Appendix C. 
Discussion 
In this study, we generated congenic mice for previously mapped Chr 1 QTLs linked to 
adiposity (Tabw3) and hypercholesterolemia (Tachol1) derived from a TH fragment on a B6 
background.  On the B6 background, the TH derived Chr1 128Mb segment, containing the 
Tabw3 and Tachol1 QTLs, produced obesity and hypercholesterolemia in B6.TH-Chr1-128Mb 
congenic mice.  However, contrary to our expectations, B6.TH-Chr1-92Mb congenic mice 
capturing the proximal segment corresponding with the Tabw3 QTL failed to develop obesity.  
The lack of obesity may suggest that the effect of Tabw3 alone may not be large enough or it 
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may require interacting with other loci in the distal segment, potentially Tachol1 or other obesity 
QTLs undetected from our original genome-wide study (Stewart et al., 2010).  In this context, 
the obesity in B6.TH-Chr1-128Mb congenic mice may reflect this complexity.  Generating 
congenic mice containing only the distal segment of Chr 1 may allow us to test this complexity.  
Daily food intake of B6.TH-Chr1-128Mb congenic mice was comparable with that of B6 
mice on both chow and HF diets, suggesting greater energy storage efficiency in the congenic 
mice than B6.  Energy expenditure determined by heat production normalized with body weight 
(kcal/kg/hr) was lower in B6.TH-Chr1-128Mb congenic mice than B6 mice.  These findings are 
consistent with the characterization of parental TH strain (Parkman et al., 2016). 
Based on the published knowledge, we tested Ifi202b and Apoa2 genes as potential 
candidate genes within the distal region of Chr 1.  It has been reported that the gene expression 
levels of Ifi202b are positively associated with the development of obesity in mice (Vogel et al., 
2017; Vogel et al., 2012). The Ifi202b (also called p202) is known to play a role in cell 
proliferation and differentiation including adipocyte differentiation (Li, Liu, Guo, Zhu, & Jiao, 
2014).  The mRNA levels of Ifi202b were significantly higher in adipose tissue from B6.TH-
Chr1-128Mb than B6 mice and they were significantly upregulated in response to HF diets, 
suggesting a potential gene-diet interaction.   
Several studies have identified highly significant cholesterol QTLs in the Tachol1 
interval and proposed the Apoa2 gene as a likely candidate (Machleder et al., 1997; J. Suto et al., 
2004; J. I. Suto & Kojima, 2017). APOA2, synthesized in liver, has an antagonist effect on 
cellular cholesterol efflux (Bandarian, Daneshpour, Hedayati, Naseri, & Azizi, 2016).  
Transgenic mice overexpressing Apoa2 develop hypercholesterolemia (Warden, Hedrick, Qiao, 
Castellani, & Lusis, 1993) while knockout of the gene in mice reduces plasma cholesterol levels 
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(Weng & Breslow, 1996).  Further, transgenic mice overexpressing Apoa2 have larger fat mass 
than controls (Castellani, Goto, & Lusis, 2001).  The TH mouse carries the APOA2-Val61 allele 
that is putatively hypermorphic in increasing cholesterol levels.  This polymorphism, however, 
does not seem to directly alter the mRNA levels of Apoa2 as they were comparable between B6 
and B6.TH-Chr1-128Mb congenic mice on chow.  It was interesting to observe that the mRNA 
levels of Apoa2 were significantly higher in B6.TH-Chr1-128Mb congenic than B6 mice on HF 
diets.   
Through bioinformatic approaches using a catalog of sequence variants between B6 and 
TH mice we generated a list of potential candidate genes (Table 5).  Among these, genes that 
cause obesity in knockout mice include the ATPase, Na+/K+ transporting, alpha 2 polypeptide 
gene (Kawakami et al. 2005) and poly (ADP-ribose) polymerase family, member 1 gene 
(Devalaraja-Narashimha & Padanilam, 2010).  On the other hand, transgenic mice 
overexpressing the upstream transcription factor 1 gene exhibit lower adiposity and lower plasma 
cholesterol levels than wild type mice (S. Wu et al., 2010).   
In addition to the genes for which obesity or cholesterol phenotype was found in 
knockout or transgenic mice, other genes are also noticeable in the list based on known function.  
The hydroxysteroid (17-beta) dehydrogenase 7 (Hsd17b7) gene encodes an enzyme required for 
the cholesterol biosynthesis in liver and is known to be downregulated in a hypocholesterolemic 
rodent model (Nemoto et al., 2013).  The phospholipase A2, group IVA (cytosolic, calcium-
dependent) (Pla2g4a) gene encodes a calcium activated enzyme that catalyzes the hydrolysis of 
membrane phospholipids to release arachidonic acid, mediating eicosanoid-driven inflammation; 
polymorphism in Pla2g4a was associated with obesity resistant phenotype in a primate model 
(Harris et al., 2016).  The C-reactive protein (Crp) gene and serum amyloid P-component (Apcs, 
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also called Sap) gene are in close proximity on Chr 1.  CRP and SAP are a superfamily of 
proteins that are characterized by pentraxin domain at the carboxyl-terminus and play key roles 
in innate immunity and inflammation (Garlanda, Bottazzi, Bastone, & Mantovani, 2005).  
Human circulating CRP (Yudkin, Stehouwer, Emeis, & Coppack, 1999) and SAP (Jenny, 
Arnold, Kuller, Tracy, & Psaty, 2007) concentrations were positively associated with BMI.  
Bochud et al. (2009) also suggested CRP as a causal factor for the obesity in human.       
In conclusion, by analysis using congenic strains, we confirmed the effect of the 128Mb 
TH segment from Chr 1 in increasing body fat and plasma cholesterol values and demonstrated 
that the distal segment of Chr 1 from TH is necessary to cause both phenotypes.  Our studies 
provided logical information regarding potential candidate genes for the Chr 1 QTL.  The 
congenic strains will be a valuable resource for the identification of genes underlying these 
complex traits and their interactions with diets.  
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CHAPTER 4 
IL-6 LEVELS AND MITOCHONDRIAL RESPIRATION IN TALLYHO AND B6.TH-
CHR1-128MB CONGENIC MICE  
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Abstract 
Obesity is a global epidemic and one of the leading causes of preventable death. The 
development of obesity is most likely due to interactions of multiple genes with obesogenic 
environments such as a high fat diet. Obesity is defined as excess adiposity that causes chronic 
secretion of pro-inflammatory cytokines, contributing to systemic low-grade inflammation. At 
the cellular level, expanded adipose tissue may cause decreased angiogenesis and hypoxia, 
increasing reactive oxygen species formation and dysfunctional mitochondria. Mitochondrial 
dysfunction and inflammation are known contributors of adipose dysfunction in obesity. The 
TALLYHO/Jng (TH) mouse is a polygenic model for obesity and type 2 diabetes.  Previously, 
we demonstrated that diets are important modulators of genetic susceptibility to obesity and type 
2 diabetes in TH mice and congenic mice carrying obesity QTL on chromosome 1 derived from 
TH mice (B6.TH-Chr1-128 Mb).  In this study, we measured pro-inflammatory cytokine IL-6 
levels and mitochondrial respiration in TH and congenic mice to elucidate mechanisms 
mediating the gene-diet interaction in the development of obesity and type 2 diabetes.  TH mice 
had significantly higher IL-6 levels in plasma than B6 mice on chow, which was exaggerated on 
high-sucrose high-fat diets (HSHF). The congenic mouse also had significantly higher levels of 
IL-6 in the plasma than B6 mice. We then examined mitochondrial respiration of white adipose 
tissue of TH, B6, and the congenic mice on chow by using the XFp Seahorse analyzer, which 
measured the oxygen consumption rate (OCR) of cells. Stromal vascular cells (SVC) from TH 
mice had significantly lower spare and maximal respirations compared to B6. SVC from B6.TH-
Chr1-128Mb congenic mice also had significantly lower spare respiration. In summary, this 
study showed that the obesity in TH and congenic mice is associated with increased systemic 
inflammation and decreased mitochondrial respiration. 
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Introduction 
Obesity is a worldwide epidemic, associated with an increased risk of type 2 diabetes 
(T2D), hypertension, hyperlipidemia, cardiovascular disease, and various cancers (Gallagher & 
LeRoith, 2015; Rhee, 2018). In the United States, nearly 60 % of the population is considered 
overweight, BMI is ≥25kg/m2 or obese, BMI is ≥30kg/m2 (Berrios, 2016) . Obesity is a complex 
disease that is attributed to interactions between obesity promoting environmental factors, such 
as a high fat (HF) diet, and genetic factors (Yazdi et al., 2015).  
Obesity is characterized by excess adipose tissue accumulation. This expansion is due to 
increased adipocyte size (hypertrophy) and/or number (hyperplasia) through adipogenesis (Shao 
et al., 2018). Adipose tissue, a storage site for excess energy in the form of triglycerides, is an 
endocrine organ involved in energy homeostasis. Adipose tissue releases multiple 
adipocytokines including leptin, adiponectin, interleukin 6 (IL-6), and tumor necrosis factor 
alpha (TNF-alpha) (Castro, Macedo-de la Concha, & Pantoja-Meléndez, 2017). Increased 
adipose tissue mass results in increasing cytokine release (Monteiro & Azevedo, 2010). 
Increased adipose mass also leads to hypoxia, followed by the apoptosis of adipocytes and the 
formation of reactive oxygen species (ROS) in the tissue (Trayhurn & Alomar, 2015). The 
structural stress due to hypertrophy, increased ROS, and increased adipocyte apoptosis leads to 
increased macrophage infiltration of adipose tissue and an increased number of cytokines, 
resulting in a pro-inflammatory environment (Alcala et al., 2017). Ultimately, chronic low-grade 
systemic inflammation develops (Majdoubi, Kishta, & Thibodeau, 2016).  
There is emerging evidence linking mitochondrial dysfunction to adipose dysfunction and 
inflammation in obesity and T2D. Mitochondria in white adipose tissue regulate several 
metabolic processes including lipogenesis, lipolysis, and fatty acid (FA) re-esterification. 
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Mitochondria are also suggested to be important in adipogenesis as studies have shown that 
adipogenesis and mitochondrial biogenesis initiation are synchronized and many of the same 
regulatory proteins are used for both processes (Boudina & Graham, 2014). When there is excess 
adipose mass and inflammation, there is decreased mitochondrial content and oxidative capacity. 
Mitochondrial dysfunction also causes increased ROS formation in the electron transport chain 
and impaired substrate oxidation, both of which contribute to adipose dysfunction (Vernochet et 
al., 2014). 
The TALLYHO/Jng (TH) mouse is a polygenic model for human obesity and T2D. It is 
characterized by increased adiposity, insulin resistance, hyperlipidemia, and hyperglycemia (Kim 
& Saxton, 2012a).  In addition, the penetrance of genetic susceptibility to obesity and T2D is 
modulated by dietary fat in TH mice (Parkman et al., 2016). In this study, we determined 
whether the gene-diet interaction in the development of obesity and T2D in TH mice could be 
attributed to inflammation and mitochondrial dysfunction.  We also included congenic mice 
carrying obesity QTL on chromosome 1 derived from TH mice on C57BL/6J (B6) background 
(B6.TH-Chr1-128Mb) (Parkman et al., 2017; Stewart et al., 2010).  
Materials and Methods 
Animals and diets 
All mice including TH, B6.TH-Chr1-128Mb congenic, and B6 mice, were bred in our 
animal facility.  All mice had access to food and water ad libitum in a temperature and humidity-
controlled room with a 12-h light/dark cycle.  At 4 weeks of age, mice were weaned onto 
standard rodent chow (14% kcal from fat, Purina 5001, PMI Nutrition, Brentwood, MO), semi-
purified high-sucrose low-fat (HSLF) diet (D12489B) (except the congenic mice), or semi-
purified high-sucrose high-fat (HSHF) diet (D12266B) (Research Diets, New Brunswick, NJ, 
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USA). The diets were maintained throughout the study. Mice were euthanized by CO2 
asphyxiation. Blood was collected by cardiac puncture and underwent centrifugation (1,200g) at 
4ºC to collect plasma, which was stored at −20°C.  Tissues were collected, frozen in liquid 
nitrogen, and stored at −80°C.  All animal studies were carried out with the approval of Marshall 
University Animal Care and Use Committee.  
RNA isolation and real-time quantitative PCR (qRT-PCR) 
Total RNA was isolated from epididymal adipose tissue using RNeasy Plus Universal 
Midi Kit according to the manufacturer’s instructions (Qiagen, Valencia, CA, USA).  Total RNA 
(2μg) was reverse-transcribed with SUPERSCRIPT RT using oligo dT as primer to synthesize 
first-strand cDNA according to the manufacturer’s instructions (Invitrogen, Waltham, MA, 
USA).  The real-time PCR reaction was carried out with 1x SYBR Green PCR core reagents 
(Qiagen) using the StepOneTM Real-Time PCR system (Thermo Fisher Scientific, Waltham, MA, 
USA for interleukin 6 (Il-6) (forward: 5’- GAGAAAAGAGTTGTGCAATGGC-3’ and reverse: 
5’- CCAGTTTGGTAGCATCCATCAT-3’) and 36B4 (forward: 5’- 
GAGGAATCAGATGAGGATATGGGA -3’ and reverse: 5’-AAGCAGGCTGACTTGGTTGC 
-3’). Duplicate amplifications were performed, and the average measurements used for data 
analysis.  
Western blot analysis 
Protein extracts were prepared from the epididymal adipose tissue of B6, B6.TH-Chr1-
128Mb, and TH mice as well as liver tissue from B6 and B6.TH-Chr1-128Mb mice with 
radioimmunoprecipitation assay (RIPA) lysis buffer (Millipore, Temecula, CA, USA). Total 
protein (50μg) from each sample was separated on 10% sodium dodecyl sulfate polyacrylamide 
gel electrophoresis (SDS-PAGE) gels and transferred to hydrophilic polyvinylidene difluoride 
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(PVDF) membranes (Millipore Sigma, Burlington, MA, USA) using a mini trans-blot apparatus 
(Bio-Rad, Hercules, CA, USA). After blocking with 5% dry milk in Tris Buffered Saline with 
Tween 20® (TBST), the membranes were probed with anti-IL-6 (sc-1265, Santa Cruz 
Biotechnology, 1:200), followed by incubation with horseradish peroxidase (HRP)-conjugated 
donkey anti-goat IgG (sc-2020, Santa Cruz Biotechnology, 1:5000). Membranes were also 
probed with HRP-conjugated anti-GAPDH (sc-25778, Santa Cruz Biotechnology, 1:1000).  
Bound antibody was detected by enhanced chemiluminescence (Mruk & Cheng, 2011) and then 
imaged using the ChemidocTM Imaging System. The bands were quantified by Image Lab 
software (Bio-Rad, USA).  
Plasma IL-6 levels 
Plasma IL-6 levels were determined using an enzyme-linked immunosorbent assay 
(ELISA) kit (Mouse IL-6 DuoSet ELISA R&D Systems, MN, USA) according to the 
manufacturer’s instructions. 
Mitochondrial respiration assay  
 Stromal vascular fraction (SVF) cells were isolated from the epididymal adipose tissue 
of B6, TH, and B6TH-Chr1-128Mb mice using procedures described in Lee et al (M. J. Lee & 
Fried, 2014). Briefly, adipose tissue was minced and washed with PBS. The minced tissue was 
digested at 37 °C for 2 hours in Collagenase I solution (Gibco® Collagenase I, Invitrogen, 
Grand Island, NY, USA, 1mg/ml) in Corning™ cellgro™ Hanks Balanced Salt Solution (Media 
Tech Inc, Manassas, VA, USA). Digested tissue was strained and centrifuged at 500g for 10 
minutes. The supernatant was aspirated and the pellet was resuspended in culture media 
(Dulbecco’s modified Eagle’s medium with L-glutamine, 4.5 g/L glucose and sodium pyruvate 
(Mediatech Inc, Manassas, VA) with the addition of 10 % (v/v) fetal bovine serum (Sigma, St. 
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Louis, MO) and 100 units/ml penicillin and 100 mg/ml streptomycin (Mediatech Inc, Manassas, 
VA)). Cells were centrifuged a second time and the aspiration and resuspension were repeated.  
XFp cell culture plate wells (Seahorse Bioscience, Agilent, Billerica, MA, USA) were coated 
with 0.1% gelatin (Eastman Kodak Company, Rochester, NY, USA). 50,000 cells were seeded in 
the XFp cell culture plates in 200 µL culture media and placed in a 37°C incubator with 5% CO2 
for 24 hours. After incubation, culture media was removed and the cells were washed twice with 
assay medium (XF base medium,10 mM glucose, 2 mM glutamine and 1 mM sodium pyruvate; 
pH 7.4, Seahorse Bioscience). Assay medium (180ul) was added to each well and the plate was 
incubated in a non- CO2 incubator for 1 hour. The prepped seahorse cartridge was loaded to a 
final concentration of 1 µM oligomycin, 1 µM carbonyl cyanide p-[trifluoromethoxy]-phenyl-
hydrazone (FCCP), and 1 µM rotenone & antimycin A in the A, B, and C injector ports 
respectively (Cell Mito stress kit, Seahorse Bioscience). The cell mito stress test assay was run 
on the XFp analyzer (Seahorse Bioscience). Total protein concentration was analyzed by BCA 
assay. Data was normalized by total protein concentration. Individual parameters for basal 
respiration, proton leak, ATP production, maximal respiration, and spare respiratory capacity 
were calculated from % oxygen consumption rate (OCR). % of OCR was calculated using basal 
measurements as 100%. Individual parameters were then calculated (Tan et al., 2015). 
Statistical analysis 
Data analysis was conducted by ANOVA with GraphPad Prism (version 7.03). Student’s 
unpaired t-tests were used when only two groups were compared. All data were presented as 
means  SEM. Significance was considered at P<0.05. (Livak & Schmittgen, 2001). 
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Results 
IL-6 levels in TH and Congenic mice 
Plasma IL-6 levels were significantly higher in TH mice than B6 mice on chow and 
HSHF (Figure 9A).  In addition to strain effect, there was diet effect; B6 mice on HSHF had 
significantly higher levels of IL-6 compared to B6 mice on chow and the same was true for TH 
mice. In epididymal adipose tissue, there was a trend of increased IL-6 protein expression levels 
in TH mice on all diets, compared to B6 mice, however it did not reach statistical significance 
(Figure 9B).  
Plasma IL-6 levels were also significantly higher in B6.TH-Chr1-128Mb congenic mice 
compared to B6 mice on chow (Figure 10A).   
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Figure 9. IL-6 expression (A) Plasma IL-6 levels (17 to 27 weeks n= 5,7 respectively) measured 
by ELISA and (B) Western blot analysis for IL-6 in epididymal adipose tissue (20-25 weeks of 
age, n=4 for each group) in male B6 and TH mice fed chow, HSLF, and HSHF diets. Mean IL-6 
content of adipose tissue is displayed as arbitrary units after normalization to glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) content levels in the same blot. Data were reported as 
means  SEM.  Group means labeled with different letters are significantly different (P<0.05).  
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In epididymal adipose tissue, there was a trend of increased Il-6 gene expression levels in 
B6.TH-Chr1-128Mb congenic mice compared to B6 mice, however, it did not reach statistical 
significance (Figure 10B). The same trend was seen in the IL-6 protein expression levels in 
epididymal adipose tissue (Figure 10C), as well as in liver (Figure 10D).  
 
  
 
Figure 10. IL-6 expression (A) Plasma IL-6 levels in male B6 and B6.TH-Chr1-128Mb 
congenic mice fed chow (16 to 19wks n= 5,6 respectively). (B) The mRNA levels of Il-6 in 
epididymal adipose tissue (18-24 weeks of age, n=5 to 6 mice) where changes in gene expression 
were expressed as fold change relative to mean value of B6 mice on chow, (C) western blot 
analysis for IL-6 in epididymal adipose tissue (20-24 weeks of age, n=4 for each group), and (D) 
western blot analysis for IL-6 in liver tissue (20-24 weeks of age, n=4 for each group), in male 
B6 and B6.TH-Chr1-128Mb congenic mice fed chow and HSHF. Mean IL-6 content of adipose 
tissue is displayed as arbitrary units after normalization to glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) content levels in the same blot. Data were reported as means  SEM.  
*P<0.05 
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Mitochondrial respiration in adipose tissue from the TH and congenic mice 
To measure the mitochondrial function in adipose tissue we used the Seahorse 
Extracellular flux analyzer (XFp).  We isolated the SVF from epididymal adipose tissue of TH 
and B6 mice and plated the cells in a gelatin coated culture plate. The first injection was 
oligomycin (1 μM), an inhibitor of ATP synthase, followed by FCCP (1 μM), a mobile ion 
carrier that disrupts the membrane potential, and finally rotenone/ antimycin A (1 μM), complex 
I and III inhibitors respectively (Figure 11A). Individual parameters were then calculated from % 
OCR (Figure 11B).  However, TH mice had significantly lower maximal and spare respirations 
compared to B6 mice. 
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Figure 11. Measurements of mitochondrial respiration (A) % oxygen consumption rate 
(OCR) by extracellular flux analysis and (B) individual parameters for basal respiration, proton 
leak, ATP production, maximal respiration, and spare respiratory calculated from %OCR. 
Adipose tissue-derived SVF from B6 and TH mice on chow were seeded to 50,000 cells/well. 
OCR was measured under basal conditions. Oligomycin (1 μM), FCCP (1 μM), rotenone/ 
antimycin A (1 μM) were sequentially added. Data are expressed as means ± SEM, n =6,5 
respectively (males, 19 to 23wks old). *P<0.05 
83 
 
 
Figure 12. Measurements of mitochondrial respiration (A) % oxygen consumption rate 
(OCR) by extracellular flux analysis and (B) individual parameters for basal respiration, proton 
leak, ATP production, maximal respiration, and spare respiration that were calculated from % 
OCR. Adipose tissue-derived SVF from B6 and B6.TH-Chr1-128Mb congenic mice on chow 
were seeded to 50,000 cells/well. OCR was measured under basal conditions and oligomycin (1 
μM), FCCP (1 μM), rotenone/ antimycin A (1 μM) were sequentially added. Data are expressed 
as means ± SEM, n = 6, 4 respectively, (males, 16 to 23wks old). *P<0.05  
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We saw a similar result when we compared SVF cells from B6 and B6.TH-Chr1-128Mb 
congenic mice (Figure 12B). B6.TH-Chr1-128Mb congenic mice had similar basal respiration, 
proton leak, and ATP production with B6 mice, but had a trend of lower maximal respiration and 
had significantly lower spare respiratory compared to B6 mice. 
Discussion 
This study examined the inflammatory marker IL-6 as well as the oxygen consumption 
rate of adipose tissue in TH and B6.TH-Chr1-128Mb congenic mice compared to B6.   
Plasma IL-6 levels were significantly increased in the TH mouse model. IL-6 levels were 
further exacerbated when the mice were on HF diets.  The finding of increased IL-6 expression 
on HF diets is in agreement with current studies of obesity (Ghosh & Ashcraft, 2013; Minihane 
et al., 2015; Shi et al., 2014). Under healthy circumstances, inflammation is seen as a protective 
mechanism. In healthy adipose tissue, inflammation is necessary for extracellular matrix (ECM)-
remodeling and angiogenesis to expand adipose tissue (Wernstedt Asterholm et al., 2014). The 
inflammation is acute and involves mainly M2 macrophage infiltration. However, in obesity the 
inflammation becomes chronic with M1 macrophage infiltration (Braune et al., 2017). IL-6 has 
been shown to be increased in both obese mice and humans in adipose tissue and plasma. IL-6 
increases lipolysis and fat oxidation, and increased concentrations of IL-6 have been linked to 
insulin resistance, T2D, and cardiovascular disease (Castro et al., 2017; Greenberg & Obin, 
2006). In tissues, IL-6 regulates T-cells by promoting differentiation, activation, and tissue 
infiltration. Additionally, IL-6 stimulates M1 macrophage polarization. Both actions contribute 
to the pro-inflammatory environment of adipose tissue (Braune et al., 2017; Xu et al., 2017). IL-
6, along with TNF-α, and IL-1β, promotes insulin resistance in peripheral tissues as well. These 
cytokines act in a paracrine and autocrine manner to activate the c-Jun N-terminal kinase (JNK) 
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and nuclear transcription factor kappa B (NF-kB) pathways which phosphorylate the insulin 
receptor substrate-1 (IRS-1), reducing expression and decreasing insulin signaling (Castro et al., 
2017; Eder, Baffy, Falus, & Fulop, 2009). For example, TNF-α stimulates increased adipocyte 
lipolysis, increasing fatty acids in the blood stream. The fatty acids interact with muscle and liver 
and activate the NF-kB pathway, promoting insulin resistance (de Luca & Olefsky, 2008; 
Greenberg & Obin, 2006). Overall, increased cytokine release by adipose and macrophages, 
including IL-6, contribute to a pro-inflammatory microenvironment which contributes to adipose 
dysfunction and obesity.  
Adipose mitochondria are known to play a role in multiple metabolic processes. Changes 
in mitochondrial oxidative capacity can lead to changes in metabolic homeostasis, which can 
contribute to the development of various diseases (Boudina & Graham, 2014; Brand & Nicholls, 
2011). While mitochondrial basal respiration in non-stressful circumstance was unchanged, 
maximum and spare respirations were significantly reduced in TH mice compared to B6 mice.  
Both decreases in respiration indicate possible mitochondrial dysfunction (Brand & Nicholls, 
2011). Decreased expression could also be indicative of a hypoxic white adipose tissue as 
oxidative phosphorylation (OXPHOS) is aerobic and an anaerobic environment would cause a 
shift to glycolysis (Schottl, Kappler, Fromme, & Klingenspor, 2015). Mitochondrial dysfunction 
is a hallmark of obesity and may be a response to energy overload (Schottl, Kappler, Fromme, et 
al., 2015). Continuous excess nutrition causes cellular stress from hypertrophy in the form of 
inflammation and increased ROS, as well as a metabolic switch to lipid storage and increased 
ATP production (De Pauw, Tejerina, Raes, Keijer, & Arnould, 2009). Adaptive changes are 
made to alter the mitochondrial network. Eventually, in both humans and mice, it has been 
shown that obese individuals have decreased mitochondrial number, decreased function, 
86 
decreased biogenesis, and decreased mitochondrial DNA including genes involved in OXPHOS. 
There is also an increase in ROS in the electron transport chain which can further increase lipid 
accumulation and hypertrophic adipocytes and decrease oxygen consumption, resulting in 
increased inflammation, adipose dysfunction, and mitochondrial dysfunction (Kusminski & 
Scherer, 2012).  
For this study, all the mice tested with Seahorse XFp analyzer were on a chow diet. 
Although there was no change to ATP production between the groups, a future study involving 
mice on the HSHF diet may exhibit decreased ATP production as high fat increases adiposity 
and inflammation, exacerbating mitochondrial dysfunction. In the future, it would also be 
beneficial to study the protein expression levels of different complexes of the electron transport 
chain for TH on different diets. 
In conclusion, the obesity and T2D in TH mice are associated with decreased oxygen 
consumption and increased inflammation, which may in part contribute to the gene-diet 
interaction for the disease susceptibility in this model. 
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CHAPTER 5 
DISCUSSION AND FUTURE DIRECTIONS 
Obesity, defined as the accumulation of excess adipose tissue, is considered one of the 
leading causes of preventable death, as it is associated with an increased risk of type 2 diabetes, 
hypertension, hyperlipidemia, cardiovascular disease, and certain cancers (Kanasaki & Koya, 
2011). Obesity is a complex, multifactorial disease that is attributed to a number of variables, 
including genetics and environment (Wright & Aronne, 2012). The genes that contribute to 
obesity, their mechanisms, and their interactions with the environment, however, remain largely 
unknown (Chu, Malinowska, Jura, & Kozak, 2017). In obesity research, animal models provide a 
platform to control environmental variables, such as diet, and the ability to use genetic 
manipulation more easily (Kanasaki & Koya, 2011). This dissertation first focused on studying 
gene-diet interactions in the development of obesity and type 2 diabetes in the TALLYHO/Jng 
(TH) mouse. Next, congenic mouse strains were developed in an effort to identify obesity 
gene(s) in TH mice. Finally, we looked into inflammation and mitochondrial respiration in TH 
and congenic mice. 
Diet dependence of obesity and type 2 diabetes in TH mice 
The TH mouse is a polygenic model for human obesity and type 2 diabetes (Kim & 
Saxton, 2012b).  The genetic basis of obesity and type 2 diabetes in TH mice has been well 
studied previously by our research group.  In this study, we examined diet dependence of obesity 
and type 2 diabetes in TH mice compared to C57BL/6J (B6) mice.  The data demonstrate high 
sensitivity of TH mice to dietary high fat in advancing obesity and type 2 diabetes, which 
provides evidence that diets are important modifiers of genetic susceptibility to obesity and type 
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2 diabetes in this model.  The interplay between heredity and dietary environment in TH mice 
appears to amplify insulin resistance, contributing to severe glucose intolerance and diabetes.  
The effect of various macronutrients on body weight regulation has been studied and 
debated for years. If the effects of protein, fat, and carbohydrates on the body can be elucidated, 
dietary intervention for obesity and type 2 diabetes will be more effective. The difficulty of 
studying the effects of macronutrients lies with the various other variables/contributors such as 
genetics, epigenetics, or the gut microbiome that are involved. The multiple variables can lead to 
variability in the effects of diet on individuals, resulting in various phenotypes from increased 
adiposity to decreased adiposity (Zeevi et al., 2015). Hu et al. (2018) reported a study where B6 
mice were given 29 different diets of various percentages of carbohydrates, protein, and fat. 
They found that only dietary fat content was responsible for increased adiposity and energy 
intake. They repeated the experiment with 4 other mouse strains, DBA/2, BALB/c, FVB, and 
C3H with the same results (S. Hu et al., 2018).  
Many diet-induced obesity model studies use extreme macronutrient diets such as 60% 
calories from fat. While there is plenty to learn from extreme phenotypes due to extreme diets, 
the development of a majority of human obesity and type 2 diabetes cases progresses much more 
gradually on a western style diet (Della Vedova et al., 2016; Mitchell, Catenacci, Wyatt, & Hill, 
2011). The high fat diet used in our study is a representation of the standard western diet, with 
high fat (31.8 kcal%) and high carbohydrate (51.4 kcal%) (Table 1). The TH mouse is a 
clinically relevant model for obesity and type 2 diabetes where genetic factors interplay with 
dietary factors, serving as a useful tool in developing and testing therapeutic targets. 
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Obesity gene(s) in TH mice 
Our previous mapping studies using F2 mice from TH and B6 mice identified 
quantitative trait loci (QTL) linked to obesity and hypercholesterolemia on chromosome 1 (Kim 
& Saxton, 2012b; Stewart et al., 2010). To identify obesity gene(s) in the QTL, we generated a 
congenic mouse strain carrying the QTL derived from TH mice on B6 background; B6.TH-Chr1-
128Mb. A nested second congenic line (proximally overlapping), B6.TH-Chr1-92Mb, was also 
generated from the first line (Figure 5). With a high fat diet (HFD) feeding, B6.TH-Chr1-128Mb 
congenic mice exhibited greater adiposity than B6.TH-Chr1-92Mb or B6 mice (Figure 6). 
B6.TH-Chr1-128Mb congenic mice also had increased plasma insulin levels, slightly impaired 
glucose tolerance, and increased total plasma cholesterol on HFD compared to B6.TH-Chr1-
92Mb or B6 mice (Figure 6). B6.TH-Chr1-128Mb congenic mice had lower energy expenditure, 
than B6.TH-Chr1-92Mb or B6 mice on chow or HFD (Table 3). The findings suggest that 
B6.TH-Chr1-128Mb congenic mice may have increased energy efficiency and decreased energy 
expenditure compared to B6.TH-Chr1-92Mb and B6 mice, resulting in the increased fat mass 
observed.  From this study we concluded that the distal segment of chromosome 1 from TH mice 
is necessary to cause obesity.  For fine mapping, we have begun to construct nested recombinant 
subcongenic lines carrying various regions of the distal segment of the QTL and established 3 
lines (B6.TH-Chr1(7)-TTT, -TT, and -T) (Fig. 13) (unpublished data).  Each nested subcongenic 
line is genetically distinct from the others for the length and the boundaries of the TH 
introgressed region.    
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Figure 13. B6.TH-Chr1 congenic intervals on chromosome 1.  Genetic markers shown at the 
top were used to allelotype the congenic interval.  The open and filled boxes represent a 
C57BL/6J (B6) and TALLYHO (TH) allele, respectively. Mb: Megabase 
 
B6.TH-Chr1(7)-TTT, B6.TH-Chr1(7)-TT, and B6.TH-Chr1(7)-T mice had significantly 
higher fat mass than B6 mice on HFD, defining the candidate region of the obesity QTL to 
marker D1Mit113.  Based on the known biological function, Ifi202b and Apoa2 genes are 
plausible positional candidate genes, and genetic variants of these genes are present between TH 
and B6 mice.  We will also search candidate genes using the published catalog of sequence 
variants in the TH mouse (relative to the B6 strain). In this study, we created new congenic mice 
for obesity that can be a valuable resource for the identification of obesity gene(s) and their 
interactions with diets.    
Higher inflammation and lower mitochondrial respiratory capacity in TH mice 
The excess adipose tissue in obesity develops inflammation through hypoxia from 
increased mass but decreased vascularization, increased apoptosis of hypertrophic cells, and 
increased infiltration of macrophages (Gutierrez, Puglisi, & Hasty, 2009). Both adipose tissue 
and macrophages secrete pro-inflammatory cytokines such as IL-6 and TNF- (Jung & Choi, 
2014). Excess free fatty acids from digestion and spill-over from adipocytes form deposits on 
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peripheral organs, increasing lipotoxicity and contributing to the development of insulin 
resistance (Sears & Perry, 2015). Cytokines from adipose tissue and peripheral organs circulate 
and cause systemic, chronic low-grade inflammation (Jung & Choi, 2014). Increased 
inflammation and oxidative stress, due to increased nutritional intake, disrupt mitochondrial 
homeostasis and lead to mitochondrial dysfunction, as mitochondria are unable to generate and 
sustain necessary ATP production (de Mello et al., 2018). Increased inflammation, adipose tissue 
dysfunction, and mitochondrial dysfunction exacerbate metabolic dysfunction and insulin 
resistance (de Mello et al., 2018; Gutierrez et al., 2009; Jung & Choi, 2014; Sears & Perry, 
2015).  
We investigated inflammation and mitochondrial respiratory activity in TH and B6.TH-
Chr1-128Mb congenic mice compared to B6 mice. It was hypothesized that TH mice would have 
increased inflammation compared to B6 mice, especially on HSHF. We found that plasma IL-6 
levels were significantly higher in TH mice than B6 mice on chow and HSHF (Figure 9).  Both 
B6 and TH mice had higher plasma IL-6 levels on HSHF compared to chow. Plasma IL-6 levels 
were also significantly higher in B6.TH-Chr1-128Mb congenic mice compared to B6 mice on 
chow (Figure 10).  
Basal respiration, proton leak, and ATP production in SVF cells from adipose tissue were 
comparable between B6 vs TH mice or B6.TH-Chr1-128Mb congenic mice (Figure 11, 12). 
However, TH mice had significantly lower maximal and spare respiratory capacity compared to 
B6 mice. B6.TH-Chr1-128Mb congenic mice had a significantly lower spare respiratory capacity 
compared to B6 mice. Our results using SVF cells are in line with previous studies using 
adipocytes from diet-induced or genetic obese models, where adipocytes were shown to have 
decreased maximal respiration and spare respiratory capacity (Pardo et al., 2011; Schottl, 
92 
Kappler, Braun, Fromme, & Klingenspor, 2015). Spare respiratory capacity is the difference 
between basal and maximal respiratory activity and is necessary for sudden large energy 
requirements. If the spare respiratory capacity cannot meet demands, then the cells may die or 
become damaged (Desler et al., 2012).  
Limitations  
In chapter 4, oxygen consumption rate (OCR) of adipose tissue-derived SVF from TH, 
B6.TH.Chr1-128Mb, and B6 mice were measured with the Seahorse XFp analyzer; however, we 
were limited to chow-fed samples only. Differences in mitochondrial respiration were found 
between TH and B6.TH-Chr1-128Mb versus B6 mice on chow, and we anticipate that we would 
observe a marked difference if HFD fed samples had they been available. The plasma IL-6 levels 
of Chr1-128Mb congenic mice were also limited to chow only and should be further investigated 
on HFD compared to B6. In addition to the diet limitation, we only plated and examined SVF 
cells that contain preadipocytes for the assay. However, previous studies have been done 
comparing SVF cells before and after differentiation, resulting in a similar trend in OCR 
(LeMieux et al., 2016).   Finally, this dissertation focused on male mice.  There is sexual 
dimorphism with adipose deposition in humans, and more studies need to be done addressing 
these differences so effective treatments for both genders can be found (Giles, Jackman, & 
MacLean, 2016).   
Conclusion 
This dissertation sought to characterize the TH mouse as a relevant, clinical model for 
human polygenic obesity and T2D. This work was the first to examine the effect of diet on the 
TH mouse model and identify that TH mice are highly sensitive to dietary fat in advancing 
obesity and T2D. The interplay between heredity and dietary environment in TH mice appears to 
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amplify insulin resistance and inflammation.  We were also able to identify obesity candidate 
loci in TH mice. TH mice will be a useful model for further candidate gene identification and 
mechanistic studies in order to advance obesity and T2D understanding and the development of 
more effective treatments. 
Future Studies 
In chapter 2, a diet study was conducted with TH and B6 mice on standard rodent chow, 
semi-purified high-sucrose low fat (HSLF) diet, and semi-purified high-sucrose high-fat (HSHF) 
diet. We found that semi-purified diets promoted weight gain before dietary fat promoted weight 
gain. The semi-purified diet effect may be due to lack of soluble fiber, which causes cecal and 
colonic atrophy and microbiota-dependent promotion of adiposity (Chassaing et al., 2015). In the 
future, it would be worthwhile to test whether this effect is microbiota dependent.  
The results in chapter 3 confirmed previous mapping studies for obesity QTL on 
chromosome 1 in TH mice. By utilizing subcongenic mice analysis combined with 
bioinformatics, we will identify obesity gene(s) derived from TH genome.  We currently have 
Apoa2, a candidate gene, knockout mice and bred them to our B6.TH-Chr1(7)-T sub-congenic 
mice. By knocking out the Apoa2 gene in B6.TH-Chr1(7)-T sub-congenic mice, we can 
investigate to what extent Apoa2 contributes to increased fat mass and plasma cholesterol seen in 
the congenic model.  
Chapter 4 began looking into adipose tissue inflammation and mitochondrial health very 
briefly. Further studies need to be done to examine the cytokine profile of TH mice on chow and 
HFD. OCR should be examined once more using the Seahorse XFp to see the effect of HFD on 
the mitochondrial parameters for TH and B6. In addition, with the availability of the Seahorse 
XFe24 analyzer, adipose tissue can be added directly to the wells of the microplate. Various 
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white adipose depots could be studied as well as brown adipose tissue. If there is evidence of 
mitochondrial dysfunction, further experiments can be conducted to uncover the location(s) of 
the dysfunction in the mitochondria by testing the different complexes of the electron transport 
chain. 
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APPENDIX B: LIST OF ABBREVIATIONS 
11β-HSD1…11β-hydroxysteroid dehydrogenase type 1 
AgRP…Agouti-related peptide 
Apoa2… Apolipoprotein A 
ARC…Arcuate nucleus 
ATP… adenosine triphosphate 
B6…C57BL/6J or C57BL/6 
BAT…Brown adipose tissue 
BMI…Body mass index  
BMPs… Bone morphogenetic proteins 
BPA…Bisphenol A 
C57BL/6J…The same as C57BL/6 
C/EBPα …CCAAT-enhancer-binding protein alpha 
CCK…Cholecystokinin 
Chr1…Chromosome 1 
CLAMS…Comprehensive Laboratory Animal Monitoring System 
CNS…Central nervous system 
CREB…cAMP response element binding protein 
CRP…C-reactive protein 
∆Ct…average threshold cycle  
DIO…Diet induced obesity 
ECM…Extracellular matrix 
EDCs…Endocrine disrupting chemicals 
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ELISA… Enzyme-linked immunosorbent assay  
ETC… Electron transport chain 
FCCP…Carbonyl cyanide p-[trifluoromethoxy]-phenyl-hydrazone 
FFA…Free fatty Acids 
FGF21… Fibroblast growth factor 21 
FRD…Fructose-rich diet 
FTO… Fat mass and obesity-associated protein 
GAPDH… Glyceraldehyde-3-phosphate dehydrogenase 
GI…Gastrointestinal tract 
GLP-1… Glucagon-like peptide 1 
GLUT4…Glucose transporter 4 
GO…Gene Ontology  
GWAS… genome-wide association studies 
HFD…High fat diet 
HRP…Horseradish peroxidase (HRP) 
Hsd17b7…Hydroxysteroid (17-beta) dehydrogenase 7 
HSHF… Semi-purified high-sucrose high-fat 
HSLF…Semi-purified high-sucrose low-fat 
Ifi202b…Interferon activated gene 202b 
IKK…IκB kinase 
IFN-γ…Interferon-γ  
IL-10…Interleukin-10 
IL-6…Interleukin-6  
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IPGTT…Intraperitoneal glucose tolerance test 
IRS-1…Insulin receptor substrate 1 
IRS-2...Insulin receptor substrate 2 
JNK… c-Jun N-terminal kinase 
LDL…Low-density lipoprotein 
LOO… C57B6 late-onset obesity mouse 
MCP-1…Monocyte chemoattractant protein  
MSCs… Multipotent mesenchymal stem cells 
Myf5…Myogenic factor 5 
NAFLD…Non-alcoholic fatty liver disease 
NEAT… Nonexercise activity thermogenesis 
NF-κB …Nuclear factor-κB 
NPY…Neuropeptide Y 
NZO…New Zealand Obese mouse  
OAD…Oral antidiabetic drugs 
OCR…Oxygen Consumption Rate 
OR…Odds ratio 
OXPHOS…Oxidative phosphorylation 
PGC-1α …Peroxisome proliferator-activated receptor-γ coactivator-1α 
Pla2g4a… The phospholipase A2, group IVA 
PNS…Parasympathetic nervous system 
POMC…Proopiomelanocortin 
PPARγ…Peroxisome proliferator-activated receptor gamma 
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PRDM16…PR domain containing 16 
PVDF…polyvinylidene difluoride  
qRT-PCR…Real-time quantitative polymerase chain reaction 
QTL…Quantitative trait loci  
RER…Respiratory exchange ratio 
RIPA… Radioimmunoprecipitation assay  
ROS…Reactive oxygen species 
SAP…Serum amyloid P-component 
SDS-PAGE…sodium dodecyl sulfate polyacrylamide gel electrophoresis  
SNS…Sympathetic nervous system 
SSLP…single sequence length polymorphism markers 
SVC…Stromal vascular cells 
SVF… Stromal vascular fraction 
T2D…Type 2 diabetes 
Tabw3…TALLYHO associated body weight 3 
Tachol1…TALLYHO associated cholesterol 1 
TBST…Tris Buffered Saline with Tween 20®  
TCA… Tricarboxylic acid 
TCF4…Transcription factor 4  
TH…TALLYHO/Jng 
TNF-α…Tumor necrosis factor alpha  
UCP-1… Uncoupling protein 1 
WAT…White adipose tissue 
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WBKDF… Wistar Bonn Kobori rats 
XFp…Extracellular flux analyzer 
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APPENDIX C:  
TABLE 5. GENES IN THE REGION FLANKED BY D1MIT498 AND D1MIT361 
Gene Variant type(s) Go Terms 
Abl2 missense_variant 
splice_donor_variant 
positive regulation of phospholipase C activity 
Acbd3 missense_variant fatty-acyl-CoA binding; lipid metabolic process 
Aldh9a1 splice_region_variant metabolic process; carnitine metabolic process; cellular 
aldehyde metabolic process 
Apcs splice_region_variant negative regulation by host of viral glycoprotein metabolic 
process; negative regulation of glycoprotein metabolic process 
Apoa2 missense_variant negative regulation of cholesterol import; high-density 
lipoprotein particle remodeling; cholesterol transporter 
activity;apolipoprotein receptor binding; high-density 
lipoprotein particle receptor binding; low-density lipoprotein 
particle remodeling; high-density lipoprotein particle clearance; 
negative regulation of cholesterol transport; cholesterol efflux; 
phospholipid efflux; phospholipid binding; fatty acid metabolic 
process; positive regulation of lipid catabolic process; 
phospholipid catabolic process; lipid transporter activity; 
triglyceride-rich lipoprotein particle remodeling; negative 
regulation of very-low-density lipoprotein particle remodeling; 
negative regulation of lipid catabolic process; lipoprotein 
metabolic process; cholesterol binding;lipid transport; 
cholesterol transport; positive regulation of cholesterol 
esterification; regulation of intestinal cholesterol absorption; 
reverse cholesterol transport; lipid binding; response to glucose; 
cholesterol metabolic process; negative regulation of lipase 
activity; high-density lipoprotein particle assembly; lipase 
inhibitor activity; high-density lipoprotein particle binding; 
negative regulation of cholesterol transporter activity; 
cholesterol homeostasis 
Atp1a2 missense_variant 
splice_region_variant 
ATP metabolic process 
Bpnt1 missense_variant 
splice_region_variant 
nucleobase-containing compound metabolic process 
Crp missense_variant negative regulation of lipid storage; low-density lipoprotein 
particle receptor binding; regulation of low-density lipoprotein 
particle clearance; cholesterol binding; low-density lipoprotein 
particle binding 
Ephx1 missense_variant 
splice_region_variant 
cellular aromatic compound metabolic process 
Eprs missense_variant 
splice_region_variant 
metabolic process 
Exo1 splice_region_variant nucleobase-containing compound metabolic process; DNA 
metabolic process 
Fh1 missense_variant 
splice_region_variant 
fumarate metabolic process; malate metabolic process 
Hhipl2 missense_variant carbohydrate metabolic process 
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splice_acceptor_variant 
splice_region_variant 
Hsd17b7 missense_variant cholesterol biosynthetic process; lipid metabolic process 
Itpkb missense_variant 
splice_region_variant 
inositol trisphosphate metabolic process 
Kmo intron_variant 
missense_variant 
splice_region_variant 
NAD metabolic process; kynurenine metabolic process 
Lamc1 missense_variant 
splice_region_variant 
glycosphingolipid binding 
Marc1 missense_variant 
splice_region_variant 
nitrate metabolic process 
Marc2 splice_region_variant nitrate metabolic process 
Mark1 missense_variant 
splice_region_variant 
lipid binding 
Mia3 inframe_insertion 
missense_variant 
splice_region_variant 
lipoprotein transporter activity; lipoprotein transport 
Ncf2 splice_region_variant superoxide metabolic process; response to glucose 
Ncstn missense_variant beta-amyloid metabolic process 
Nit1 missense_variant 
splice_region_variant 
nitrogen compound metabolic process 
Npl splice_region_variant metabolic process; carbohydrate metabolic process 
Parp1 splice_region_variant mitochondrial DNA metabolic process; DNA metabolic process 
Pex19 splice_region_variant negative regulation of lipid binding 
Pla2g4a splice_region_variant metabolic process; calcium-dependent phospholipase A2 
activity;calcium-dependent phospholipid binding; phospholipase 
A2 activity; phospholipid catabolic process; lipid metabolic 
process; lysophospholipase activity; phospholipase activity; 
lipid catabolic process; arachidonic acid metabolic process 
Ppox splice_region_variant protoporphyrinogen IX metabolic process 
Psen2 missense_variant 
splice_region_variant 
cellular protein metabolic process; beta-amyloid metabolic 
process 
Rab3gap2 missense_variant 
splice_region_variant 
positive regulation of protein lipidation 
Rnasel missense_variant 
splice_region_variant 
fat cell differentiation; positive regulation of glucose import in 
response to insulin stimulus 
Soat1 missense_variant 
splice_region_variant 
cholesterol O-acyltransferase activity;cholesterol efflux; 
cholesterol binding; cholesterol metabolic process; cholesterol 
storage; very-low-density lipoprotein particle assembly; lipid 
metabolic process; steroid metabolic process; cholesterol 
homeostasis; cholesterol esterification 
Tnr missense_variant sphingolipid binding 
Uap1 missense_variant 
splice_region_variant 
metabolic process; UDP-N-acetylglucosamine metabolic 
process 
Usf1 inframe_deletion glucose metabolic process; positive regulation of transcription 
from RNA polymerase II promoter by glucose; lipid 
homeostasis 
Table 5. Genes in the region flanked by D1Mit498 and D1Mit361 with protein-altering 
variants that are associated with obesity-related Gene Ontology terms. 
